US3972059A
(en)
|
1973-12-28 |
1976-07-27 |
International Business Machines Corporation |
Dielectric diode, fabrication thereof, and charge store memory therewith
|
IT1197388B
(it)
|
1985-10-18 |
1988-11-30 |
Westinghouse Electric Corp |
Comando di sgancio con sensore per reattore nucleare
|
IL125071A0
(en)
|
1996-01-17 |
1999-01-26 |
Novo Nordisk As |
Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives their preparation and use
|
CN1271086C
(zh)
|
1996-08-30 |
2006-08-23 |
诺沃挪第克公司 |
Glp-1衍生物
|
IL127296A
(en)
|
1996-12-31 |
2003-01-12 |
Reddy Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
KR20010021936A
(ko)
|
1997-07-16 |
2001-03-15 |
한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 |
융합된 1,2,4-티아디아진 유도체, 그의 제조와 사용
|
CZ295889B6
(cs)
|
1998-12-07 |
2005-11-16 |
Societe De Conseils De Recherches Et D'application |
Analogy GLP-1, mající arginin na pozicích 26 a 34, jejich použití a farmaceutické prostředky je obsahující
|
YU72201A
(sh)
|
1999-04-28 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh. |
Derivati di-aril kiseline kao ppar receptorski ligandi
|
AU782404B2
(en)
|
1999-04-28 |
2005-07-28 |
Sanofi-Aventis Deutschland Gmbh |
Tri-aryl acid derivatives as PPAR receptor ligands
|
JP4763949B2
(ja)
|
1999-06-23 |
2011-08-31 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
置換されたベンゾイミダゾール
|
DE19929709C2
(de)
|
1999-06-24 |
2001-07-12 |
Lueder Gerking |
Verfahren zur Herstellung von im Wesentlichen endlosen feinen Fäden und Verwendung der Vorrichtung zur Durchführung des Verfahrens
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
AU7476800A
(en)
|
1999-09-10 |
2001-04-10 |
Novo Nordisk A/S |
Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
YU84702A
(sh)
|
2000-06-22 |
2005-09-19 |
Pfizer Inc. |
Novi postupak za pripremanje pirazolopirimidinona
|
AU2001279616A1
(en)
|
2000-08-25 |
2002-03-04 |
Novo-Nordisk A/S |
Sam
|
CN102250071A
(zh)
|
2000-12-21 |
2011-11-23 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的吡唑化合物
|
TWI311133B
(en)
|
2001-04-20 |
2009-06-21 |
Eisai R&D Man Co Ltd |
Carboxylic acid derivativeand the salt thereof
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
IL160556A0
(en)
|
2001-08-31 |
2004-07-25 |
Aventis Pharma Gmbh |
Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
|
WO2003044000A1
(en)
|
2001-11-22 |
2003-05-30 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
CA2466490C
(en)
|
2001-11-22 |
2009-12-29 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
CA2466733A1
(en)
|
2001-11-22 |
2003-05-30 |
Meredith Williams |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
JP4368683B2
(ja)
|
2002-02-01 |
2009-11-18 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病、肥満症および脂質代謝異常の治療に有用な11−ベータ−ヒドロキシステロイドデヒドロゲナーゼ1阻害剤
|
AU2003215325B8
(en)
|
2002-03-05 |
2008-10-09 |
Eli Lilly And Company |
Purine derivatives as kinase inhibitors
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
DE10215907A1
(de)
|
2002-04-11 |
2003-11-06 |
Aventis Pharma Gmbh |
Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
JPWO2003097064A1
(ja)
|
2002-05-17 |
2005-09-15 |
協和醗酵工業株式会社 |
糖尿病治療剤
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
DE10226462A1
(de)
|
2002-06-13 |
2003-12-24 |
Aventis Pharma Gmbh |
Fluorierte Cycloalkyl-derivatisierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
PL373329A1
(en)
|
2002-07-12 |
2005-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
|
MXPA05001009A
(es)
|
2002-07-27 |
2005-05-16 |
Astrazeneca Ab |
Cetonas.
|
AU2003250539A1
(en)
|
2002-08-07 |
2004-02-25 |
Mitsubishi Pharma Corporation |
Dihydropyrazolopyridine compounds
|
DE10237723A1
(de)
|
2002-08-17 |
2004-07-08 |
Aventis Pharma Deutschland Gmbh |
Verwendung von IKappaB-Kinase Inhibitoren in der Schmerztherapie
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
BR0314098A
(pt)
|
2002-09-05 |
2005-07-19 |
Aventis Pharma Sa |
Derivados da aminoindazóis a tìtulo de medicamentos e composições farmacêuticas que os contêm
|
PL375878A1
(en)
|
2002-09-12 |
2005-12-12 |
F.Hoffmann-La Roche Ag |
N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
|
US20050256159A1
(en)
|
2002-10-11 |
2005-11-17 |
Astrazeneca Ab |
1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors
|
JP4352001B2
(ja)
|
2002-10-18 |
2009-10-28 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病の治療または予防のためのベータ−アミノ複素環式ジペプチジルペプチダーゼ阻害剤
|
CA2501228A1
(en)
|
2002-10-24 |
2004-05-06 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
AU2003291342A1
(en)
|
2002-11-05 |
2004-06-07 |
Arena Pharmaceuticals, Inc. |
Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
|
WO2004041264A1
(en)
|
2002-11-07 |
2004-05-21 |
Astrazeneca Ab |
2-oxo-ethanesulfonamide derivates
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
US7576108B2
(en)
|
2003-01-06 |
2009-08-18 |
Eli Lilly And Company |
Substituted arylcyclopropylacetamides as glucokinase activators
|
WO2004065380A1
(en)
|
2003-01-14 |
2004-08-05 |
Arena Pharmaceuticals Inc. |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
JP4621198B2
(ja)
|
2003-02-11 |
2011-01-26 |
プロシディオン・リミテッド |
トリ(シクロ)置換アミドグルコキナーゼ活性化化合物
|
CN100361992C
(zh)
|
2003-02-19 |
2008-01-16 |
霍夫曼-拉罗奇有限公司 |
用作pepck抑制剂的磺酰胺取代的黄嘌呤
|
EP1460075A1
(en)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives
|
DE602004025220D1
(de)
|
2003-04-11 |
2010-03-11 |
High Point Pharmaceuticals Llc |
Pharmazeutische verwendungen von kondensierten 1,2,4-triazolen
|
ATE467616T1
(de)
|
2003-04-11 |
2010-05-15 |
High Point Pharmaceuticals Llc |
Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase
|
EP1615637A1
(en)
|
2003-04-11 |
2006-01-18 |
Novo Nordisk A/S |
Pharmaceutical use of substituted 1,2,4-triazoles
|
CA2524436A1
(en)
|
2003-05-09 |
2004-11-25 |
Merck & Co., Inc. |
Benzimidazoles, compositions containing such compounds and methods of use
|
US7090355B2
(en)
|
2003-05-19 |
2006-08-15 |
Superimaging, Inc. |
System and method for a transparent color image display utilizing fluorescence conversion of nano particles and molecules
|
US7067529B2
(en)
|
2003-05-19 |
2006-06-27 |
Hoffmann-La Roche Inc. |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
|
AU2004240885A1
(en)
|
2003-05-21 |
2004-12-02 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I
|
US8026264B2
(en)
|
2003-05-29 |
2011-09-27 |
Merck Sharp And Dohme Corp. |
Triazole derivatives as inhibitors of 11-β hydroxysteroid dehydrogenase-1
|
WO2004106343A2
(en)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
WO2005000836A1
(en)
|
2003-06-13 |
2005-01-06 |
Janssen Pharmaceutica N.V. |
Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors
|
SE0301886D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use V
|
SE0301882D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use I
|
SE0301888D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use VII
|
WO2004113310A1
(en)
|
2003-06-25 |
2004-12-29 |
Biovitrum Ab |
Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
DE10334309A1
(de)
|
2003-07-28 |
2005-03-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
EP1653949A4
(en)
|
2003-08-07 |
2009-04-22 |
Merck & Co Inc |
PYRAZOL CARBOXAMIDE AS AN INHIBITOR OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1
|
KR101241862B1
(ko)
|
2003-09-19 |
2013-03-13 |
노보 노르디스크 에이/에스 |
신규 glp-1 유도체
|
TW200519105A
(en)
|
2003-10-20 |
2005-06-16 |
Lg Life Science Ltd |
Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
US8008525B2
(en)
|
2003-11-26 |
2011-08-30 |
Takeda Pharmaceutical Company Limited |
Receptor function regulating agent
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
EP1557417B1
(en)
|
2003-12-19 |
2007-03-07 |
Sanofi-Aventis |
Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a] pyrimidin-6-one derivatives
|
CA2547785A1
(en)
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Cyclic guanidines, compositions containing such compounds and methods of use
|
JP2007515490A
(ja)
|
2003-12-22 |
2007-06-14 |
アムジェン インコーポレーティッド |
アリールスルホンアミド化合物およびそれに関連する使用法
|
CA2549955A1
(en)
|
2003-12-24 |
2005-07-07 |
Prosidion Limited |
Heterocyclic derivatives as gpcr receptor agonists
|
JP2007517800A
(ja)
|
2004-01-06 |
2007-07-05 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
糖尿病および肥満を処置するためのグリコーゲンホスホリラーゼインヒビターとしての(3−オキソ−3,4−ジヒドロ−キノキサリン−2−イル−アミノ)−ベンズアミド誘導体および関連化合物
|
EP1713803B1
(de)
|
2004-01-31 |
2009-08-05 |
Sanofi-Aventis Deutschland GmbH |
7-phenylamino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
EP1718625A1
(en)
|
2004-02-18 |
2006-11-08 |
AstraZeneca AB |
Compounds
|
CA2558585C
(en)
*
|
2004-02-27 |
2010-10-12 |
Amgen Inc. |
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
|
DE102004010194A1
(de)
|
2004-03-02 |
2005-10-13 |
Aventis Pharma Deutschland Gmbh |
4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
|
WO2005085237A1
(ja)
|
2004-03-04 |
2005-09-15 |
Kissei Pharmaceutical Co., Ltd. |
縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
|
EP1722789A2
(en)
|
2004-03-08 |
2006-11-22 |
Amgen Inc. |
Therapeutic modulation of ppar (gamma) activity
|
DE102004012068A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
CA2560314A1
(en)
|
2004-03-29 |
2005-10-20 |
Merck & Co., Inc. |
Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
EP1586318A1
(en)
|
2004-04-05 |
2005-10-19 |
Neuropharma S.A.U. |
Thiadiazolidinones as GSK-3 inhibitors
|
EP1732566A4
(en)
|
2004-04-05 |
2010-01-13 |
Takeda Pharmaceutical |
6-azaindole COMPOUND
|
WO2005097076A2
(en)
|
2004-04-09 |
2005-10-20 |
Smithkline Beecham Corporation |
Low dose pharmaceutical products
|
MXPA06012870A
(es)
|
2004-05-12 |
2007-02-15 |
Aventis Pharma Inc |
Acido 2-{[2-(2- metilaminopirimidin -4-il)-1h- indol-5 -carbonil]amino}-3 -(fenilpiridin -2-ilamino) propionico sustancialmente puro como inhibidor de la cinasa ikb.
|
EP1604988A1
(en)
|
2004-05-18 |
2005-12-14 |
Sanofi-Aventis Deutschland GmbH |
Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
|
DE102004026532A1
(de)
|
2004-05-29 |
2006-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
DE102004028241B4
(de)
|
2004-06-11 |
2007-09-13 |
Sanofi-Aventis Deutschland Gmbh |
Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
|
BRPI0512630A
(pt)
|
2004-06-24 |
2008-03-25 |
Incyte Corp |
compostos de amido e seu uso como produtos farmacêuticos
|
CA2570694A1
(en)
|
2004-06-24 |
2006-02-02 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
DE102004034697A1
(de)
|
2004-07-17 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Mit Diphenylamin oder Diphenylaminderivaten substituierte Salicylthiazole, Verfahren zu deren Herstellung und deren Verwendung
|
DE602005008079D1
(de)
|
2004-07-28 |
2008-08-21 |
Hoffmann La Roche |
Aryl-pyridinderivate als 11-beta-hsd1-hemmer
|
DE102004037554A1
(de)
|
2004-08-03 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038270A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102004038268A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Pyrrolidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP2008509146A
(ja)
|
2004-08-06 |
2008-03-27 |
メルク エンド カムパニー インコーポレーテッド |
11−ベータ−ヒドロキシステロイドデヒドロゲナーゼ−1の阻害剤としてのスルホニル化合物
|
DE102004038269A1
(de)
|
2004-08-06 |
2006-03-16 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
BRPI0514147A
(pt)
|
2004-08-12 |
2008-05-27 |
Prosidion Ltd |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos de tratamento profilático ou terapêutico de uma condição onde a ativação de gk é desejável, de tratamento profilático ou terapêutico da hiperglicemia ou diabete e de prevenção da diabete em um ser humano que demosntra hiperglicemia pré-diabética ou toleráncia à glicose prejudicada, e, processo para a preparação do composto
|
DE102004039507A1
(de)
|
2004-08-14 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
CA2577373A1
(en)
|
2004-08-18 |
2006-03-02 |
Metabasis Therapeutics, Inc. |
Novel thiazole inhibitors of fructose 1,6-bisphosphatase
|
DE602005018509D1
(de)
|
2004-08-30 |
2010-02-04 |
Janssen Pharmaceutica Nv |
N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer
|
BRPI0515168A
(pt)
|
2004-09-11 |
2008-07-08 |
Sanofi Aventis Deutschland |
7-azaindóis, processos para sua preparação e seu uso como fármacos
|
KR100856164B1
(ko)
|
2004-09-29 |
2008-09-03 |
에프. 호프만-라 로슈 아게 |
11β-하이드록시스테로이드 데하이드로게나제 1억제제로서의 인도졸론 유도체
|
CA2581922A1
(en)
|
2004-09-29 |
2006-04-06 |
Kissei Pharmaceutical Co., Ltd. |
1-(.beta.-d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof
|
WO2006039325A2
(en)
|
2004-10-01 |
2006-04-13 |
Merck & Co., Inc. |
Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
JP5107713B2
(ja)
|
2004-10-07 |
2012-12-26 |
ノヴォ ノルディスク アー/エス |
遅延性のエキセンディン−4化合物
|
WO2006037810A2
(en)
|
2004-10-07 |
2006-04-13 |
Novo Nordisk A/S |
Protracted glp-1 compounds
|
WO2006040329A1
(en)
|
2004-10-12 |
2006-04-20 |
Novo Nordisk A/S |
1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds
|
WO2006045564A1
(en)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Xanthine derivatives with hm74a receptor activity
|
RU2007118932A
(ru)
|
2004-10-22 |
2008-11-27 |
Смитклайн Бичам Корпорейшн (US) |
Производные ксантина с активностью нм74а
|
SI1807072T1
(sl)
|
2004-10-29 |
2009-06-30 |
Lilly Co Eli |
Derivati cikloalkil laktamov kot inhibitorji 11-beta-hidroksisteroid dehidrogenaze 1
|
WO2006048750A2
(en)
|
2004-11-02 |
2006-05-11 |
Pfizer Inc. |
Novel compounds of substituted and unsubstituted adamantyl amides
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
EP1659113A1
(en)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
|
WO2006051662A1
(ja)
|
2004-11-09 |
2006-05-18 |
Taisho Pharmaceutical Co., Ltd. |
チアゾール誘導体
|
JP2006160733A
(ja)
|
2004-11-15 |
2006-06-22 |
Taisho Pharmaceut Co Ltd |
シアノフルオロピロリジン誘導体を有効成分として含有する医薬
|
AU2006283062B2
(en)
|
2005-08-26 |
2011-04-14 |
Merck Sharp & Dohme Corp. |
Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
CA2587800C
(en)
|
2004-11-29 |
2012-06-12 |
Merck & Co., Inc. |
Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
WO2006059744A1
(ja)
|
2004-11-30 |
2006-06-08 |
Nippon Chemiphar Co., Ltd. |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
WO2006058923A1
(en)
|
2004-12-03 |
2006-06-08 |
Novo Nordisk A/S |
Heteroaromatic glucokinase activators
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
WO2006068163A1
(ja)
|
2004-12-24 |
2006-06-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
二環性ピロール誘導体
|
WO2006065826A2
(en)
|
2004-12-15 |
2006-06-22 |
Merck & Co., Inc. |
Process to chiral beta amino acid derivatives by asymmetric hydrogenation
|
DE102004060542A1
(de)
|
2004-12-16 |
2006-07-06 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
|
JP2008524244A
(ja)
|
2004-12-17 |
2008-07-10 |
タケダ サン ディエゴ インコーポレイテッド |
水酸化ステロイド脱水素酵素阻害剤
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
KR20070091038A
(ko)
|
2004-12-24 |
2007-09-06 |
프로시디온 리미티드 |
G-단백질 결합 수용체(gpr116) 효능제 및 비만 및당뇨병을 치료하기 위한 이의 용도
|
US8193359B2
(en)
|
2004-12-24 |
2012-06-05 |
Prosidion Limited |
G-protein coupled receptor agonists
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
MX2007008238A
(es)
|
2005-01-05 |
2007-08-17 |
Abbott Lab |
Derivados de adamantilo como inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo 1.
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
DE102005001053A1
(de)
|
2005-01-07 |
2006-07-20 |
Merck Patent Gmbh |
Quadratsäurederivate
|
WO2006073167A1
(ja)
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
DE102005002130A1
(de)
|
2005-01-17 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
|
DE602006010320D1
(de)
|
2005-01-19 |
2009-12-24 |
Merck & Co Inc |
Bicyclische pyrimidine als dipeptidylpeptidase-iv-hemmer zur behandlung bzw. prävention von diabetes
|
JP2008100916A
(ja)
|
2005-01-24 |
2008-05-01 |
Dainippon Sumitomo Pharma Co Ltd |
インドール類およびそれを含む医薬組成物
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
AU2006210503B2
(en)
|
2005-02-03 |
2009-09-03 |
Irm Llc |
Compounds and compositions as PPAR modulators
|
JPWO2006085685A1
(ja)
|
2005-02-09 |
2008-06-26 |
武田薬品工業株式会社 |
ピラゾール化合物
|
BRPI0607015A2
(pt)
|
2005-02-11 |
2009-12-01 |
Lilly Co Eli |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto
|
GB0503053D0
(en)
|
2005-02-14 |
2005-03-23 |
Smithkline Beecham Corp |
Chemical compounds
|
WO2006085112A1
(en)
|
2005-02-14 |
2006-08-17 |
Smithkline Beecham Corporation |
Anthranilic acid derivatives as hm74a receptor agonists
|
GB0503056D0
(en)
|
2005-02-14 |
2005-03-23 |
Smithkline Beecham Corp |
Chemical compounds
|
WO2006087997A1
(ja)
|
2005-02-15 |
2006-08-24 |
Kissei Pharmaceutical Co., Ltd. |
1-置換-7-(β-D-グリコピラノシルオキシ)(アザ)インドール化合物、及びそれを含有する医薬
|
JP2008530174A
(ja)
|
2005-02-15 |
2008-08-07 |
ノボ ノルディスク アクティーゼルスカブ |
3,4−ジヒドロ−1h−イソキノリン−2−カルボン酸5−アミノピリジン−2−イルエステル
|
AU2006217677A1
(en)
|
2005-02-25 |
2006-08-31 |
Takeda Pharmaceutical Company Limited |
Pyridyl acetic acid compounds
|
JP4632817B2
(ja)
|
2005-03-09 |
2011-02-16 |
株式会社リコー |
レンズ鏡胴、カメラ、携帯型情報端末機及び画像入力装置
|
TW200632736A
(en)
|
2005-03-11 |
2006-09-16 |
Ulead Systems Inc |
Rewritable medium, management method thereof, and related device
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012874A1
(de)
|
2005-03-19 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
TW200722432A
(en)
|
2005-03-25 |
2007-06-16 |
Sankyo Co |
Thiazole compounds
|
TWI357902B
(en)
|
2005-04-01 |
2012-02-11 |
Lg Life Science Ltd |
Dipeptidyl peptidase-iv inhibiting compounds, meth
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
CA2603757A1
(en)
|
2005-04-13 |
2006-10-26 |
Merck & Co., Inc. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
ES2338041T3
(es)
|
2005-04-15 |
2010-05-03 |
Boehringer Ingelheim International Gmbh |
Derivados de (heteroariloxi-bencil)-benceno sustituidos con glucopiranosilo en calidad de inhibidores de sglt.
|
DE102005017605B4
(de)
|
2005-04-16 |
2007-03-15 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US8957070B2
(en)
|
2005-04-20 |
2015-02-17 |
Takeda Pharmaceutical Company Limited |
Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
|
DE102005018389A1
(de)
|
2005-04-20 |
2006-10-26 |
Sanofi-Aventis Deutschland Gmbh |
Azolderivate als Inhibitoren von Lipasen und Phospholipasen
|
EP1883419A4
(en)
|
2005-05-06 |
2010-08-04 |
Bayer Pharmaceuticals Corp |
GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND THEIR PHARMACOLOGICAL USES
|
EP1881850B1
(en)
|
2005-05-13 |
2010-09-29 |
Eli Lilly And Company |
Glp-1 pegylated compounds
|
CA2608405A1
(en)
|
2005-05-17 |
2006-11-23 |
Schering Corporation |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
|
EP1888066B1
(en)
|
2005-05-25 |
2012-01-11 |
Merck Sharp & Dohme Corp. |
Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
WO2006132436A1
(ja)
|
2005-06-08 |
2006-12-14 |
Japan Tobacco Inc. |
複素環化合物
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
WO2006134467A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
N-(pyridin-2-yl)-sulfonamide derivatives
|
WO2006134481A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
|
US20080200527A1
(en)
|
2005-06-17 |
2008-08-21 |
Carex Sa |
Cannabinoid Receptor Modulators
|
US7572808B2
(en)
|
2005-06-17 |
2009-08-11 |
Bristol-Myers Squibb Company |
Triazolopyridine cannabinoid receptor 1 antagonists
|
US7605289B2
(en)
|
2005-06-17 |
2009-10-20 |
Amgen, Inc. |
Benzamide derivatives and uses related thereto
|
KR100970055B1
(ko)
|
2005-06-22 |
2010-07-16 |
에프. 호프만-라 로슈 아게 |
6-(플루오로-벤조[1,3]디옥솔일)-모폴린-4-일-메탄온 및cb1 리간드로서 그의 용도
|
JP5113046B2
(ja)
|
2005-06-28 |
2013-01-09 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ナイアシン受容体アゴニスト、このような化合物を含有する組成物及び治療の方法
|
WO2007000445A1
(en)
|
2005-06-29 |
2007-01-04 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
AT8564U1
(de)
|
2005-06-29 |
2006-09-15 |
Plansee Se |
Halogenglühlampe mit abblendkappe aus mo-legierung
|
BRPI0612599A2
(pt)
|
2005-06-30 |
2010-11-23 |
Prosidion Ltd |
composto, composição farmacêutica compreendendo o mesmo, método de tratamento e uso do mesmo
|
US20090325924A1
(en)
|
2005-06-30 |
2009-12-31 |
Stuart Edward |
GPCR Agonists
|
ATE520670T1
(de)
|
2005-07-05 |
2011-09-15 |
Hoffmann La Roche |
Pyridazinderivate
|
CA2614518A1
(en)
|
2005-07-08 |
2007-01-18 |
Novo-Nordisk A/S |
Dicycloalkyl urea glucokinase activators
|
WO2007007688A1
(ja)
|
2005-07-08 |
2007-01-18 |
Mochida Pharmaceutical Co., Ltd. |
3,5-ジアミノ-1,2,4-トリアゾール誘導体
|
US20110053910A1
(en)
|
2005-07-09 |
2011-03-03 |
Mckerrecher Darren |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
RU2420525C2
(ru)
|
2005-07-11 |
2011-06-10 |
Мицубиси Танабе Фарма Корпорейшн |
Производные оксимов и их получение
|
AU2006267338B2
(en)
|
2005-07-13 |
2012-08-16 |
Msd K.K. |
Heterocycle-substituted benzimidazole derivative
|
CN101263131B
(zh)
|
2005-07-14 |
2013-04-24 |
特兰斯特克药品公司 |
脲葡糖激酶活化剂
|
ATE432259T1
(de)
|
2005-07-20 |
2009-06-15 |
Lilly Co Eli |
Pyridinderivate als dipeptedyl-peptidase-hemmer
|
WO2007015744A1
(en)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Disubstituted thienyl compounds and their use as pharmaceuticals
|
ATE449097T1
(de)
|
2005-07-21 |
2009-12-15 |
Hoffmann La Roche |
Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
US8153694B2
(en)
|
2005-07-29 |
2012-04-10 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
FR2889190A1
(fr)
|
2005-08-01 |
2007-02-02 |
Merck Sante Soc Par Actions Si |
Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant
|
ES2267400B1
(es)
|
2005-08-04 |
2008-03-01 |
Universitat De Valencia |
Composiciones pigmentarias en base acuosa para marcado policromatico de materiales inorganicos con laser.
|
WO2007017649A1
(en)
|
2005-08-09 |
2007-02-15 |
Astrazeneca Ab |
Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
|
EA014556B1
(ru)
|
2005-08-10 |
2010-12-30 |
ГЛЭКСОСМИТКЛАЙН ЭлЭлСи |
Производные ксантина в качестве селективных агонистов hm74a
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
AU2006285064A1
(en)
|
2005-08-29 |
2007-03-08 |
Merck Sharp & Dohme Corp. |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
WO2007026761A1
(ja)
|
2005-08-31 |
2007-03-08 |
Astellas Pharma Inc. |
チアゾール誘導体
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
WO2007028145A2
(en)
|
2005-09-02 |
2007-03-08 |
Dara Biosciences, Inc. |
Agents and methods for reducing protein tyrosine phosphatase 1b activity in the central nervous system
|
US20080300251A1
(en)
|
2005-09-05 |
2008-12-04 |
Sattigeri Jitendra A |
Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
|
MXPA05009633A
(es)
|
2005-09-08 |
2007-03-07 |
Silanes Sa De Cv Lab |
Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
|
GB2429975A
(en)
|
2005-09-08 |
2007-03-14 |
Univ Edinburgh |
1,5-substituted-1H-tetrazole 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
EP1924546A1
(en)
|
2005-09-14 |
2008-05-28 |
Amgen, Inc |
Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
|
WO2007035355A2
(en)
|
2005-09-16 |
2007-03-29 |
Arena Pharmaceuticals, Inc. |
Modulators of metabolism and the treatment of disorders related thereto
|
EP1928874A1
(en)
|
2005-09-16 |
2008-06-11 |
AstraZeneca AB |
Heterobicyclic compounds as glucokinase activators
|
JP2009508963A
(ja)
|
2005-09-21 |
2009-03-05 |
インサイト・コーポレイション |
アミド化合物および医薬組成物としてのその使用
|
NZ566875A
(en)
|
2005-09-29 |
2010-06-25 |
Sanofi Aventis |
Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmacueticals
|
GT200600428A
(es)
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
US7799820B2
(en)
|
2005-09-30 |
2010-09-21 |
Banyu Pharmaceutical Co., Ltd. |
2-Heterocycle-substituted indole derivatives for treating diabetes and associated conditions
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
DE102005048897A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
TW200745031A
(en)
|
2005-10-13 |
2007-12-16 |
Merck & Co Inc |
Acyl indoles, compositions containing such compounds and methods of use
|
JP2009013065A
(ja)
|
2005-10-14 |
2009-01-22 |
Astellas Pharma Inc |
縮合へテロ環化合物
|
CN103724335A
(zh)
|
2005-10-20 |
2014-04-16 |
默沙东公司 |
用作11β-羟基类固醇脱氢酶-1抑制剂的***衍生物
|
WO2007053765A2
(en)
|
2005-11-01 |
2007-05-10 |
Janssen Pharmaceutica N.V. |
Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
|
CN101355938A
(zh)
|
2005-11-01 |
2009-01-28 |
高点制药有限责任公司 |
取代的酰胺的药学应用
|
CA2628274A1
(en)
|
2005-11-01 |
2007-05-10 |
Array Biopharma Inc. |
Glucokinase activators
|
EA200801243A1
(ru)
|
2005-11-01 |
2008-10-30 |
Транстек Фарма |
Фармацевтическое применение замещенных амидов
|
US20080293741A1
(en)
|
2005-11-03 |
2008-11-27 |
Matthew Colin Thor Fyfe |
Tricyclo Substituted Amides as Glucokinase Modulators
|
EP1948645A1
(en)
|
2005-11-03 |
2008-07-30 |
Prosidion Limited |
Tricyclo substituted amides
|
EP1948644A1
(en)
|
2005-11-03 |
2008-07-30 |
Prosidion Limited |
Tricyclo substituted amides
|
UA95613C2
(ru)
|
2005-11-09 |
2011-08-25 |
Уеллстат Терепьютикс Корпорейшн |
Соединения для лечения расстройсв метаболизма
|
PT1951658E
(pt)
|
2005-11-17 |
2012-11-12 |
Lilly Co Eli |
Antagonistas do receptor do glucagon, preparação e utilizações terapêuticas
|
DK1951661T3
(da)
|
2005-11-17 |
2012-09-03 |
Lilly Co Eli |
Glucagonreceptorantagonister, fremstilling og terapeutiske anvendelser deraf
|
WO2007057768A2
(en)
|
2005-11-18 |
2007-05-24 |
Pfizer Products Inc. |
Sulfonyl derivatives
|
EP1948614A2
(en)
|
2005-11-18 |
2008-07-30 |
Takeda San Diego, Inc. |
Glucokinase activators
|
AU2006316087B2
(en)
|
2005-11-21 |
2011-03-10 |
Shionogi & Co., Ltd. |
Heterocyclic compound having inhibitory activity on 11-beta-hydroxysteroid dehydrogenase type I
|
CN101312723B
(zh)
|
2005-11-22 |
2012-01-11 |
伊莱利利公司 |
胰高血糖素受体拮抗剂、制备和治疗用途
|
MX2008006530A
(es)
|
2005-11-22 |
2008-09-25 |
Amgen Inc |
Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1.
|
AU2006342059B2
(en)
|
2005-11-23 |
2012-05-10 |
Eli Lilly And Company |
Glucagon receptor antagonists, preparation and therapeutic uses
|
WO2007060992A1
(ja)
|
2005-11-25 |
2007-05-31 |
Kaneka Corporation |
メタボリックシンドロームもしくはインスリン抵抗性症候群の予防または改善剤
|
WO2007063928A1
(ja)
|
2005-11-30 |
2007-06-07 |
Toray Industries, Inc. |
新規な非環状アミンカルボキシアミド誘導体及びその塩
|
CN1978445B
(zh)
|
2005-12-02 |
2010-09-01 |
中国科学院上海药物研究所 |
一种可用作人源腺苷单核苷酸激活蛋白激酶激活剂的化合物及其制备方法和应用
|
CA2631737C
(en)
|
2005-12-14 |
2013-03-26 |
Merck & Co., Inc. |
Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
|
US7825122B2
(en)
|
2005-12-14 |
2010-11-02 |
Amgen Inc. |
Diaza heterocyclic sulfonamide derivatives and their uses
|
EP1801098A1
(en)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
EP1973548A4
(en)
|
2005-12-19 |
2010-02-24 |
Tufts College |
LIGHT PROTEASES INHIBITORS AND THEIR LIGHT PROFORMS
|
CA2633584A1
(en)
|
2005-12-20 |
2007-07-05 |
Takeda Pharmaceutical Company Limited |
Glucokinase activators
|
EP1966193B1
(en)
|
2005-12-21 |
2010-09-29 |
F. Hoffmann-La Roche AG |
New salt and polymorph of dpp-iv inhibitor
|
CA2633740A1
(en)
|
2005-12-22 |
2007-06-28 |
Crystalgenomics, Inc. |
Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
|
WO2007071766A2
(en)
|
2005-12-22 |
2007-06-28 |
Transtech Pharma |
Phenoxy acetic acids as ppar delta activators
|
EP1966215A1
(en)
|
2005-12-23 |
2008-09-10 |
Novartis AG |
Condensed heterocyclic compounds useful as dpp-iv inhibitors
|
US20090156465A1
(en)
|
2005-12-30 |
2009-06-18 |
Sattigeri Jitendra A |
Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
|
WO2007081755A2
(en)
|
2006-01-09 |
2007-07-19 |
Metabasis Therapeutics, Inc. |
Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
|
UY30082A1
(es)
|
2006-01-11 |
2007-08-31 |
Boehringer Ingelheim Int |
Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
|
EP1973915A4
(en)
|
2006-01-13 |
2010-08-25 |
Merck Sharp & Dohme |
TRIAZONE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1
|
EP1976509B1
(en)
|
2006-01-18 |
2014-12-17 |
Evolva SA |
Ppar modulators
|
WO2007083978A1
(en)
|
2006-01-23 |
2007-07-26 |
Crystalgenomics, Inc. |
Imidazopyridine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
|
CN101007798B
(zh)
|
2006-01-24 |
2011-01-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
苯并间二氧杂环戊烯衍生物及其制备方法和医药用途
|
CA2636757A1
(en)
|
2006-01-25 |
2007-08-02 |
Tesfaye Biftu |
Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
CN101007804B
(zh)
|
2006-01-25 |
2011-05-11 |
中国人民解放军军事医学科学院毒物药物研究所 |
1,3-苯并间二氧杂环戊烯-2,2-二羧酸衍生物、其制备方法和医疗用途
|
JP5236499B2
(ja)
|
2006-01-27 |
2013-07-17 |
アレイ バイオファーマ、インコーポレイテッド |
グルコキナーゼ活性化剤
|
US20090137610A1
(en)
|
2006-01-30 |
2009-05-28 |
Irm Llc |
Spiro imidozole derivatives as ppar modulators
|
CN101360743A
(zh)
|
2006-01-30 |
2009-02-04 |
Irm责任有限公司 |
作为ppar调节剂的多环的1,2,3,4-四氢-异喹啉衍生物和包含它们的组合物
|
CN101356178A
(zh)
|
2006-01-30 |
2009-01-28 |
Irm责任有限公司 |
作为ppar调节剂的化合物和组合物
|
AU2007210018A1
(en)
|
2006-01-31 |
2007-08-09 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
CA2641609A1
(en)
|
2006-02-07 |
2007-08-16 |
Wyeth |
11-beta hsd1 inhibitors
|
JP2009526058A
(ja)
|
2006-02-07 |
2009-07-16 |
メルク エンド カムパニー インコーポレーテッド |
ナイアシン受容体アゴニスト、該化合物を含有する組成物及び治療の方法
|
US8044243B2
(en)
|
2006-02-13 |
2011-10-25 |
Wellstat Therapeutics Corporation |
Compounds for the treatment of metabolic disorders
|
DE102006006648A1
(de)
|
2006-02-14 |
2007-08-23 |
Merck Patent Gmbh |
Mandelsäurehydrazide
|
KR20080102395A
(ko)
|
2006-02-15 |
2008-11-25 |
베링거 인겔하임 인터내셔날 게엠베하 |
글루코피라노실-치환된 벤조니트릴 유도체, 당해 화합물을 함유하는 약제학적 조성물, 이들의 용도 및 이들의 제조방법
|
CA2640924C
(en)
|
2006-02-15 |
2013-10-08 |
Merck & Co., Inc. |
Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
DK1989192T3
(da)
|
2006-02-27 |
2009-11-02 |
Cadila Healthcare Ltd |
1,3-dioxane carboxylsyrer
|
EP1988772B1
(en)
|
2006-02-28 |
2011-10-26 |
Wellstat Therapeutics Corporation |
Compounds for the treatment of metabolic disorders
|
WO2007099385A1
(en)
|
2006-03-01 |
2007-09-07 |
Glenmark Pharmaceuticals S.A. |
Dipeptidyl peptidase iv inhibitor compounds and compositions
|
US7834178B2
(en)
|
2006-03-01 |
2010-11-16 |
Bristol-Myers Squibb Company |
Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
|
US20070213311A1
(en)
|
2006-03-02 |
2007-09-13 |
Yun-Long Li |
Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
WO2007100027A1
(ja)
|
2006-03-02 |
2007-09-07 |
Daiichi Sankyo Company, Limited |
光学活性なチアゾリジンジオン誘導体
|
WO2007103252A2
(en)
|
2006-03-03 |
2007-09-13 |
Merck & Co., Inc. |
Novel crystalline forms of antidiabetic compounds
|
US20070208001A1
(en)
|
2006-03-03 |
2007-09-06 |
Jincong Zhuo |
Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
|
US20070270492A1
(en)
|
2006-03-06 |
2007-11-22 |
Avestha Gengraine Technologies Pvt. Ltd. |
Nananoic acid derivatives as dipeptidyl peptidase inhibitors
|
US20080051452A1
(en)
|
2006-03-06 |
2008-02-28 |
Avestha Gengraine Technologies Pvt. Ltd. |
Hexanoic acid derivatives as dipeptidyl peptidase inhibitors
|
JP2009132620A
(ja)
|
2006-03-07 |
2009-06-18 |
Astellas Pharma Inc |
フェニルチアゾール誘導体
|
WO2007104034A2
(en)
|
2006-03-08 |
2007-09-13 |
Takeda San Diego, Inc. |
Glucokinase activators
|
CA2645719A1
(en)
|
2006-03-09 |
2007-09-13 |
High Point Pharmaceuticals, Llc |
Compounds that modulate ppar activity, their preparation and use
|
CN101454325A
(zh)
|
2006-03-09 |
2009-06-10 |
法马科皮亚公司 |
用于治疗代谢性疾病的8-杂芳基嘌呤mnk2抑制剂
|
WO2007105650A1
(ja)
|
2006-03-10 |
2007-09-20 |
Ajinomoto Co., Inc. |
4-ヒドロキシイソロイシン誘導体および同誘導体の製造方法
|
CA2646430A1
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
CN101400698A
(zh)
|
2006-03-15 |
2009-04-01 |
诺沃-诺迪斯克有限公司 |
胰岛淀粉样多肽衍生物
|
ZA200807451B
(en)
|
2006-03-16 |
2010-01-27 |
Astellas Pharma Inc |
A triazole derivative or salt thereof
|
JP5243696B2
(ja)
|
2006-03-17 |
2013-07-24 |
田辺三菱製薬株式会社 |
ベンゼン誘導体
|
CA2646588A1
(en)
|
2006-03-21 |
2007-09-27 |
High Point Pharmaceuticals, Llc |
Adamantane derivatives for the treatment of the metabolic syndrome
|
CN101405270B
(zh)
|
2006-03-22 |
2013-01-16 |
霍夫曼-拉罗奇有限公司 |
作为11-β-HSD-1的吡唑类
|
JP2009530390A
(ja)
|
2006-03-23 |
2009-08-27 |
アムゲン インコーポレイティッド |
1−フェニルスルホニル−ジアザ複素環アミド化合物およびヒドロキシステロイドデヒドロゲナーゼ調節因子としてのその使用
|
AU2007229850A1
(en)
|
2006-03-23 |
2007-10-04 |
Merck & Co., Inc. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
JP5377284B2
(ja)
|
2006-03-24 |
2013-12-25 |
アレイ バイオファーマ、インコーポレイテッド |
グルコキナーゼアクチベーターとしての2−アミノピリジンアナログ
|
FR2898892A1
(fr)
|
2006-03-24 |
2007-09-28 |
Genfit Sa |
Derives de n-(phenethyl)benzamide substitues,preparation et utilisations
|
FR2898894B1
(fr)
|
2006-03-24 |
2008-06-06 |
Genfit Sa |
Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
|
JP2007291075A
(ja)
|
2006-03-27 |
2007-11-08 |
Sankyo Co Ltd |
新規化合物ステレニン及びその製造方法
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
TW200806669A
(en)
|
2006-03-28 |
2008-02-01 |
Merck & Co Inc |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
DE102006014688A1
(de)
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
GB0606429D0
(en)
|
2006-03-30 |
2006-05-10 |
Novartis Ag |
Organic compounds
|
KR20080110882A
(ko)
|
2006-03-31 |
2008-12-19 |
노파르티스 아게 |
PTPase의 티아디아졸리디논 억제제
|
JP2009531390A
(ja)
|
2006-03-31 |
2009-09-03 |
ノバルティス アクチエンゲゼルシャフト |
有機化合物
|
CA2682846C
(en)
|
2006-04-03 |
2015-05-12 |
Matrix Laboratories Ltd. |
Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
|
WO2007114532A1
(en)
|
2006-04-03 |
2007-10-11 |
Industry-Academic Cooperation Foundation Gyeongsang National University |
Novel chalcone derivatives, pharmaceutically acceptable salt, method for preparation and uses thereof
|
CN101050194B
(zh)
|
2006-04-05 |
2013-08-21 |
上海恒瑞医药有限公司 |
双环辛烷类衍生物、其制备方法及其在医药上的用途
|
BRPI0710839A2
(pt)
|
2006-04-06 |
2011-08-23 |
Prosidion Ltd |
agonistas heterocìclicos de gpcr
|
AU2007236116A1
(en)
|
2006-04-07 |
2007-10-18 |
Develogen Aktiengesellschaft |
Thienopyrimidines having MnKl /Mnk2 inhibiting activity for pharmaceutical compositions
|
CA2648074A1
(en)
|
2006-04-07 |
2007-10-18 |
High Point Pharmaceuticals, Llc |
11.beta.-hydroxysteroid dehydrogenase type 1 active compounds
|
US7435833B2
(en)
|
2006-04-07 |
2008-10-14 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
US20090170891A1
(en)
|
2006-04-11 |
2009-07-02 |
Colletti Steven L |
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
|
GB0607196D0
(en)
|
2006-04-11 |
2006-05-17 |
Prosidion Ltd |
G-protein coupled receptor agonists
|
PE20080184A1
(es)
|
2006-04-11 |
2008-03-28 |
Novartis Ag |
Derivados de aza-biciclo[3.2.1]octan en el tratamiento de diabetes
|
WO2007116092A1
(en)
|
2006-04-12 |
2007-10-18 |
Probiodrug Ag |
Enzyme inhibitors
|
AU2007238897A1
(en)
|
2006-04-12 |
2007-10-25 |
Wyeth |
Anilino-pyrimidine phenyl and benzothiophene analogs
|
AU2007238574B2
(en)
|
2006-04-13 |
2011-08-18 |
Ipsen Pharma S.A.S. |
Pharmaceutical compositions of hGLP-1, exendin-4 and analogs thereof
|
JP2007284090A
(ja)
|
2006-04-14 |
2007-11-01 |
Dic Plastics Inc |
蓋体の係止構造および容器
|
WO2007119837A1
(ja)
|
2006-04-14 |
2007-10-25 |
Ajinomoto Co., Inc. |
リパーゼ阻害剤
|
CA2649735C
(en)
|
2006-04-18 |
2016-02-09 |
Nippon Chemiphar Co., Ltd. |
Activating agent for peroxisome proliferator activated receptor .delta.
|
UY30288A1
(es)
|
2006-04-18 |
2007-08-31 |
Janssen Pharmaceutica Nv |
Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol
|
WO2007120102A1
(en)
|
2006-04-19 |
2007-10-25 |
Astrazeneca Ab |
New substituted oxindole derivatives
|
EP2010520B1
(en)
|
2006-04-20 |
2012-09-12 |
Pfizer Products Inc. |
Heterobicyclic amides for the prevention and treatment of glucokinase-mediated diseases
|
JP2009534423A
(ja)
|
2006-04-20 |
2009-09-24 |
アムジェン インコーポレイテッド |
Glp−1化合物
|
WO2007122970A1
(ja)
|
2006-04-20 |
2007-11-01 |
Osaka University |
核内受容体に結合するリガンド
|
US7842713B2
(en)
|
2006-04-20 |
2010-11-30 |
Pfizer Inc |
Fused phenyl amido heterocyclic compounds
|
NZ571175A
(en)
|
2006-04-21 |
2011-10-28 |
Lilly Co Eli |
Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
WO2007124337A1
(en)
|
2006-04-21 |
2007-11-01 |
Eli Lilly And Company |
Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
|
MX2008013328A
(es)
|
2006-04-21 |
2008-10-27 |
Lilly Co Eli |
Derivados de lactamas de ciclohexilimidazol como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1.
|
DK2029529T3
(da)
|
2006-04-24 |
2010-09-20 |
Lilly Co Eli |
Substitueret pyrrolidinone som inhibitor af 11-beta-hydroxysteroiddehydrogenase 1
|
ATE472542T1
(de)
|
2006-04-24 |
2010-07-15 |
Lilly Co Eli |
11-beta-hydroxysteroid-dehydrogenase-1-hemmer
|
US7998999B2
(en)
|
2006-04-24 |
2011-08-16 |
Eli Lilly And Company |
Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
TW200815377A
(en)
|
2006-04-24 |
2008-04-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
WO2007122634A2
(en)
|
2006-04-24 |
2007-11-01 |
Jubilant Biosys Limited |
Pyrimidinediones as tyrosine kinase inhibitors
|
MX2008013656A
(es)
|
2006-04-25 |
2008-11-10 |
Lilly Co Eli |
Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa.
|
US7968585B2
(en)
|
2006-04-25 |
2011-06-28 |
Eli Lilly And Company |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
CN101454310B
(zh)
|
2006-04-25 |
2013-07-17 |
伊莱利利公司 |
11-β-羟类固醇脱氢酶1的抑制剂
|
WO2007122411A1
(en)
|
2006-04-26 |
2007-11-01 |
Astrazeneca Ab |
Diazepan-1-yl-sulfonyl derivatives for the treatment of metabolic syndrome
|
WO2007126043A1
(ja)
|
2006-04-27 |
2007-11-08 |
Mitsubishi Tanabe Pharma Corporation |
チアゾール環を含むカルボン酸誘導体の医薬用途
|
EP1849785A1
(en)
|
2006-04-28 |
2007-10-31 |
Neuropharma, S.A. |
N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
|
WO2007125103A2
(en)
|
2006-04-28 |
2007-11-08 |
Transtech Pharma, Inc. |
Benzamide glucokinase activators
|
ES2354917T3
(es)
|
2006-04-28 |
2011-03-21 |
Transtech Pharma, Inc. |
Activadores de la benzamidaglucoquinasa.
|
KR101060016B1
(ko)
|
2006-04-28 |
2011-08-29 |
일라이 릴리 앤드 캄파니 |
11-베타-히드록시스테로이드 데히드로게나제 1의 억제제로서의 피페리디닐 치환 피롤리디논
|
US20070293529A1
(en)
|
2006-05-01 |
2007-12-20 |
Yun-Long Li |
Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
|
EP1854806A1
(en)
|
2006-05-02 |
2007-11-14 |
MPG Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Thioglycosides as pharmaceutically active agents
|
JP2009167103A
(ja)
|
2006-05-02 |
2009-07-30 |
Taisho Pharmaceutical Co Ltd |
ピラゾリル5−チオグリコシド化合物
|
JP2009167104A
(ja)
|
2006-05-02 |
2009-07-30 |
Taisho Pharmaceutical Co Ltd |
フェニル5−チオグリコシド化合物
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
CN107235980A
(zh)
|
2006-05-04 |
2017-10-10 |
勃林格殷格翰国际有限公司 |
多晶型
|
EP2023940B1
(en)
|
2006-05-05 |
2011-06-22 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of sglt2
|
WO2007128801A1
(en)
|
2006-05-08 |
2007-11-15 |
Novartis Ag |
Combination of organic compounds
|
WO2007128817A2
(en)
|
2006-05-09 |
2007-11-15 |
Novo Nordisk A/S |
Insulin derivative
|
WO2007128815A1
(en)
|
2006-05-09 |
2007-11-15 |
Novo Nordisk A/S |
Insulin derivative
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102006021872B4
(de)
|
2006-05-11 |
2008-04-17 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102006021874B4
(de)
|
2006-05-11 |
2008-03-27 |
Sanofi-Aventis |
4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2007131621A1
(de)
|
2006-05-11 |
2007-11-22 |
Sanofi-Aventis |
4,5-diphenyl-pyrimidinyl substituierte carbonsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
WO2007136572A2
(en)
|
2006-05-15 |
2007-11-29 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
US7851468B2
(en)
|
2006-05-15 |
2010-12-14 |
Cephalon, Inc. |
Substituted pyrazolo[3,4-d]pyrimidines
|
CA2650619A1
(en)
|
2006-05-16 |
2007-11-29 |
Merck And Co., Inc. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
AU2007254357B2
(en)
|
2006-05-16 |
2011-07-21 |
Merck Sharp & Dohme Corp. |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
CA2652375A1
(en)
|
2006-05-17 |
2007-11-29 |
Incyte Corporation |
Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same
|
CA2651598A1
(en)
|
2006-05-18 |
2007-11-29 |
Wellstat Therapeutics Corporation |
Compounds for the treatment of metabolic disorders
|
US7973012B2
(en)
|
2006-05-19 |
2011-07-05 |
Taisho Pharmaceutical Co., Ltd |
C-phenyl glycitol compound
|
US7803778B2
(en)
|
2006-05-23 |
2010-09-28 |
Theracos, Inc. |
Glucose transport inhibitors and methods of use
|
WO2007135427A1
(en)
|
2006-05-23 |
2007-11-29 |
Astrazeneca Ab |
1,4-disubstituted piperazine and 1,4-disubstituted azepane as 11 -beta-hydroxysteroid dehydrogenase 1 inhibitors
|
BRPI0711879A2
(pt)
|
2006-05-23 |
2012-01-10 |
Hoffmann La Roche |
compostos, processo para a sua manufatura, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas de hm74a e usos dos compostos
|
JP5105297B2
(ja)
|
2006-05-25 |
2012-12-26 |
味の素株式会社 |
Ppar活性調節剤
|
MY147954A
(en)
|
2006-05-26 |
2013-02-15 |
Nestec Sa |
Methods of use and nutritional compositions of touchi extract
|
US20100240641A1
(en)
|
2006-05-26 |
2010-09-23 |
Julien Papillon |
Aldosterone Synthase and/or 11B-hydroxylase Inhibitors
|
US8008332B2
(en)
|
2006-05-31 |
2011-08-30 |
Takeda San Diego, Inc. |
Substituted indazoles as glucokinase activators
|
EP2032548A1
(en)
|
2006-06-01 |
2009-03-11 |
F.Hoffmann-La Roche Ag |
Thiazole derivatives
|
FR2901792A1
(fr)
|
2006-06-06 |
2007-12-07 |
Negma Lerads Soc Par Actions S |
DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE
|
JP2009190971A
(ja)
|
2006-06-06 |
2009-08-27 |
Mitsubishi Tanabe Pharma Corp |
2−シアノピロリジン誘導体
|
TW200808695A
(en)
|
2006-06-08 |
2008-02-16 |
Amgen Inc |
Benzamide derivatives and uses related thereto
|
US20070287674A1
(en)
|
2006-06-08 |
2007-12-13 |
Hej Research Institute Of Chemistry |
New treatment of diabetes mellitus
|
ES2349887T3
(es)
|
2006-06-08 |
2011-01-12 |
Amgen Inc. |
Derivados de benzamida y usos relacionados con los mismos.
|
WO2007146761A2
(en)
|
2006-06-12 |
2007-12-21 |
Neurogen Corporation |
Diaryl pyrimidinones and related compounds
|
WO2008035359A2
(en)
|
2006-06-12 |
2008-03-27 |
Cadila Healthcare Limited |
Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives
|
US20090306048A1
(en)
|
2006-06-16 |
2009-12-10 |
John Paul Kilburn |
Pharmaceutical use of substituted piperidine carboxamides
|
WO2007149865A2
(en)
|
2006-06-19 |
2007-12-27 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of ceramide synthesis
|
WO2007148185A2
(en)
|
2006-06-21 |
2007-12-27 |
Pfizer Products Inc. |
Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
|
CA2656039A1
(en)
|
2006-06-23 |
2007-12-27 |
Incyte Corporation |
Purinone derivatives as hm74a agonists
|
KR20090025262A
(ko)
|
2006-06-23 |
2009-03-10 |
인사이트 코포레이션 |
Hm74a 아고니스트로서 푸리논 유도체
|
DE102006028862A1
(de)
|
2006-06-23 |
2007-12-27 |
Merck Patent Gmbh |
3-Amino-imidazo[1,2-a]pyridinderivate
|
TW200815417A
(en)
|
2006-06-27 |
2008-04-01 |
Astrazeneca Ab |
New compounds II
|
PE20080212A1
(es)
|
2006-06-27 |
2008-04-25 |
Sanofi Aventis |
Derivados de ureas de piperidina o pirrolidina como moduladores de la 11b-hidroxiesteroide deshidrogenasa tipo 1 (11bhsd1)
|
TW200815418A
(en)
|
2006-06-27 |
2008-04-01 |
Astrazeneca Ab |
New compounds I
|
PT2248812E
(pt)
|
2006-06-27 |
2014-03-12 |
Takeda Pharmaceutical |
Compostos cíclicos fundidos como moduladores do receptor gpr40
|
PE20080344A1
(es)
|
2006-06-27 |
2008-06-09 |
Sanofi Aventis |
Compuestos 8-azabiciclo[3.2.1]oct-8-il-1,2,3,4-tetrahidroquinolina sustituidos como inhibidores 11b-hsd1
|
US20080004281A1
(en)
|
2006-06-28 |
2008-01-03 |
Kalypsys, Inc. |
Methods for the modulation of crp by the selective modulation of ppar delta
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
CN101479254B
(zh)
|
2006-06-29 |
2012-05-30 |
大正制药株式会社 |
C-苯基1-硫代山梨醇化合物
|
US20080004325A1
(en)
|
2006-06-29 |
2008-01-03 |
Wyeth |
PTP1B inhibitors
|
RU2417989C2
(ru)
|
2006-07-05 |
2011-05-10 |
Ф.Хоффманн-Ля Рош Аг |
ПРОИЗВОДНЫЕ АЛКИЛПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ 11β-ГИДРОКСИСТЕРОИДДЕГИДРОГЕНАЗЫ ТИПА 1 (11β-HSD1)
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
US7910747B2
(en)
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
US7888504B2
(en)
|
2006-07-06 |
2011-02-15 |
Bristol-Myers Squibb Company |
Glucokinase activators and methods of using same
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
WO2008005910A2
(en)
|
2006-07-06 |
2008-01-10 |
Bristol-Myers Squibb Company |
Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
|
JP5194588B2
(ja)
|
2006-07-06 |
2013-05-08 |
大正製薬株式会社 |
1−チオ−d−グルシトール誘導体を有効成分として含有する糖尿病の予防又は治療剤
|
US20080009534A1
(en)
|
2006-07-07 |
2008-01-10 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
US7795291B2
(en)
|
2006-07-07 |
2010-09-14 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents and method
|
CN101100458A
(zh)
|
2006-07-07 |
2008-01-09 |
上海艾力斯医药科技有限公司 |
具有PPARγ激动剂活性的双苯并咪唑衍生物及其应用
|
FR2903404B1
(fr)
|
2006-07-10 |
2008-08-22 |
Servier Lab |
Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
EP2043744A2
(en)
|
2006-07-13 |
2009-04-08 |
SmithKline Beecham Corporation |
Chemical compounds
|
FR2903695B1
(fr)
|
2006-07-13 |
2008-10-24 |
Merck Sante Soc Par Actions Si |
Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
EP1878721A1
(en)
|
2006-07-13 |
2008-01-16 |
Novo Nordisk A/S |
4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
US8048908B2
(en)
|
2006-07-13 |
2011-11-01 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
JP5372318B2
(ja)
|
2006-07-14 |
2013-12-18 |
パナソニック株式会社 |
電気化学キャパシタの製造方法
|
US20100010530A1
(en)
|
2006-07-14 |
2010-01-14 |
Ams Research Corporation |
Balloon Dilation for Implantable Prosthesis
|
DE102006033140A1
(de)
|
2006-07-18 |
2008-01-24 |
Merck Patent Gmbh |
Aminoindazolharnstoffderivate
|
EP2051977A2
(en)
|
2006-07-20 |
2009-04-29 |
Amgen Inc. |
SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1
|
AU2007274598A1
(en)
|
2006-07-21 |
2008-01-24 |
Lupin Limited |
Antidiabetic azabicyclo [3. 1. 0] hexan compounds
|
FR2903984B1
(fr)
|
2006-07-24 |
2008-10-03 |
Genfit Sa |
Derives d'imidazolones substitues, preparation et utilisations
|
TWI418556B
(zh)
|
2006-07-27 |
2013-12-11 |
Mitsubishi Tanabe Pharma Corp |
吲哚衍生物
|
WO2008012532A2
(en)
|
2006-07-27 |
2008-01-31 |
Astrazeneca Ab |
: pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase
|
TWI432446B
(zh)
|
2006-07-27 |
2014-04-01 |
Chugai Pharmaceutical Co Ltd |
稠環螺酮縮醇衍生物、及其做為糖尿病治療藥之使用
|
TWI403516B
(zh)
|
2006-07-27 |
2013-08-01 |
Chugai Pharmaceutical Co Ltd |
To replace spirocyclic alcohol derivatives, and its use as a therapeutic agent for diabetes
|
JP2008031064A
(ja)
|
2006-07-27 |
2008-02-14 |
Astellas Pharma Inc |
ジアシルピペラジン誘導体
|
US20080027014A1
(en)
|
2006-07-28 |
2008-01-31 |
Tanabe Seiyaku Co., Ltd. |
Novel SGLT inhibitors
|
WO2008016730A2
(en)
|
2006-08-02 |
2008-02-07 |
Targeted Molecular Diagnostics, Llc |
Compositions and methods for reducing cellular fat
|
JP5270545B2
(ja)
|
2006-08-03 |
2013-08-21 |
タフツ ユニバーシティー/トラスティーズ オブ タフツ カレッジ |
フラッシングのないナイアシン類似体およびそれらの使用法
|
WO2008016175A1
(fr)
|
2006-08-03 |
2008-02-07 |
Nippon Chemiphar Co., Ltd. |
Agent activant de récepteur activé par les proliférateurs des peroxysomes
|
US8492378B2
(en)
|
2006-08-03 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
GSK-3β inhibitor
|
TW200817424A
(en)
|
2006-08-04 |
2008-04-16 |
Daiichi Sankyo Co Ltd |
Benzylphenyl glucopyranoside derivatives
|
WO2008019309A1
(en)
|
2006-08-04 |
2008-02-14 |
Metabasis Therapeutics, Inc. |
Novel inhibitors of fructose 1,6-bisphosphatase
|
KR100826108B1
(ko)
|
2006-08-04 |
2008-04-29 |
한국화학연구원 |
퓨란-2-카복실산 유도체 및 그의 제조 방법
|
EP1887006A1
(en)
|
2006-08-07 |
2008-02-13 |
Krka |
Polymorphic forms of rosiglitazone base
|
WO2008017670A1
(en)
|
2006-08-08 |
2008-02-14 |
Boehringer Ingelheim International Gmbh |
Pyrrolo [3, 2 -d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus
|
WO2008022015A2
(en)
|
2006-08-11 |
2008-02-21 |
Trustees Of Tufts College |
Retro-inverso incretin analogues, and methods of use thereof
|
EP2054426A1
(en)
|
2006-08-15 |
2009-05-06 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
|
JP2009256208A
(ja)
|
2006-08-17 |
2009-11-05 |
Dainippon Sumitomo Pharma Co Ltd |
フタリド誘導体またはその薬学的に許容される塩
|
AU2007284365A1
(en)
|
2006-08-17 |
2008-02-21 |
Amylin Pharmaceuticals, Inc. |
DPP-IV resistant GIP hybrid polypeptides with selectable properties
|
AU2007287319A1
(en)
|
2006-08-23 |
2008-02-28 |
Pfizer Products Inc. |
Pyrimidone compounds as GSK-3 inhibitors
|
US7727978B2
(en)
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
WO2008024497A2
(en)
|
2006-08-25 |
2008-02-28 |
Vitae Pharmaceuticals, Inc. |
INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1
|
WO2008029217A2
(en)
|
2006-08-29 |
2008-03-13 |
Orchid Research Laboratories Limited |
Dipeptidyl peptidase iv inhibitors
|
EP2059516A1
(en)
|
2006-08-30 |
2009-05-20 |
BIOVITRUM AB (publ) |
Pyridine compounds for treating gpr119 related disorders
|
CL2007002499A1
(es)
|
2006-08-30 |
2008-03-14 |
Phenomix Corp |
Sales citrato y tartrato de compuestos derivados de acido pirrolidinilaminoacetilpirrolidinboronico, inhibidores de dpp-iv; metodo de preparacion; forma solida; combinacion farmaceutica, util para el tratamiento de diabetes.
|
WO2008028188A2
(en)
|
2006-09-01 |
2008-03-06 |
The Ticket Reserve |
Demand aggregation for future items contingent upon threshold demand
|
MX2009002239A
(es)
|
2006-09-01 |
2009-04-27 |
Vertex Pharma |
Derivados de 5-(2-furil)-1,3-tiazol util como inhibidores de fosfatidilinositol 3-cinasa.
|
JP2008063256A
(ja)
|
2006-09-06 |
2008-03-21 |
Astellas Pharma Inc |
β‐アミノ酸誘導体
|
EP2064193A1
(en)
|
2006-09-07 |
2009-06-03 |
Amgen, Inc |
Heterocyclic gpr40 modulators
|
WO2008028662A1
(en)
|
2006-09-07 |
2008-03-13 |
Santhera Pharmaceuticals (Schweiz) Ag |
N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment of type 2 diabetes mellitus
|
AU2007292816B2
(en)
|
2006-09-07 |
2011-11-17 |
Amgen Inc. |
Benzo-fused compounds for use in treating metabolic disorders
|
EP2114897A2
(en)
|
2006-09-12 |
2009-11-11 |
Pfizer Products Inc. |
Benzimidazolone derivatives
|
WO2008033931A1
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Para-xylylene carboxylic acids and isothiazolones useful as protein tyrosine phosphatases (ptps) in particular ptp-ib
|
WO2008033934A1
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted heteroaryl carboxylic acid derivatives as ptb-1b inhibitors
|
WO2008033932A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
|
WO2008033455A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
|
ES2370873T3
(es)
|
2006-09-13 |
2011-12-23 |
Takeda Pharmaceutical Company Limited |
Utilización del 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo para el tratamiento de la diabetes, el cáncer, los trastornos autoinmunitarios y la infección por el vih.
|
WO2008034032A2
(en)
|
2006-09-14 |
2008-03-20 |
Azevan Pharmaceuticals, Inc. |
Beta-lactam cannabinoid receptor modulators
|
CA2664095A1
(en)
|
2006-09-21 |
2008-03-27 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
HUE029512T2
(en)
|
2006-09-22 |
2017-03-28 |
Novo Nordisk As |
Protease Resistant Insulin Analogs
|
KR101077309B1
(ko)
|
2006-09-29 |
2011-10-26 |
에프. 호프만-라 로슈 아게 |
설폰아미드 유도체
|
TWI499414B
(zh)
|
2006-09-29 |
2015-09-11 |
Lexicon Pharmaceuticals Inc |
鈉與葡萄糖第2型共同運輸體(co-transporter 2)的抑制物與其應用方法
|
WO2008039882A1
(en)
|
2006-09-30 |
2008-04-03 |
Sanofi-Aventis U.S. Llc |
A combination of niacin and a prostaglandin d2 receptor antagonist
|
AU2007323035B2
(en)
|
2006-10-03 |
2011-11-24 |
Cadila Healthcare Limited |
Antidiabetic compounds
|
TW200821284A
(en)
|
2006-10-03 |
2008-05-16 |
Merck & Co Inc |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
AR063028A1
(es)
|
2006-10-06 |
2008-12-23 |
Banyu Pharma Co Ltd |
Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen.
|
WO2008044656A1
(fr)
|
2006-10-06 |
2008-04-17 |
Taisho Pharmaceutical Co., Ltd. |
Dérivé d'imidazolidinone
|
WO2008040974A1
(en)
|
2006-10-07 |
2008-04-10 |
Peakdale Molecular Limited |
Indoles for use as dpp-iv inhibitors
|
CA2675511A1
(en)
|
2006-10-10 |
2008-04-17 |
Amgen Inc. |
N-aryl pyrazole compounds for use against diabetes
|
EP1911747A1
(en)
|
2006-10-11 |
2008-04-16 |
Laboratorios del Dr. Esteve S.A. |
Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators
|
WO2008044700A1
(fr)
|
2006-10-11 |
2008-04-17 |
Takeda Pharmaceutical Company Limited |
INHIBITEUR DE LA GSK-3β
|
US7705005B2
(en)
|
2006-10-13 |
2010-04-27 |
Glaxo Group Limited |
Bicyclic heteroaromatic compounds
|
US20100093744A1
(en)
|
2006-10-13 |
2010-04-15 |
Chugai Seiyaku Kabushiki Kaisha |
Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes
|
US20080107725A1
(en)
|
2006-10-13 |
2008-05-08 |
Albano Antonio A |
Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
|
CN106982382B
(zh)
|
2006-10-16 |
2020-10-16 |
维德约股份有限公司 |
用于在可分级视频编码中信令并执行时间级切换的***和方法
|
DE102006048728A1
(de)
|
2006-10-16 |
2008-04-17 |
Merck Patent Gmbh |
3-Amino-imidazo{1,2-a]pyridinderivate
|
US8492405B2
(en)
|
2006-10-18 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity
|
JP5260507B2
(ja)
|
2006-10-19 |
2013-08-14 |
武田薬品工業株式会社 |
インドール化合物
|
EP2308851A1
(en)
|
2006-10-19 |
2011-04-13 |
F. Hoffmann-La Roche AG |
Imidazolone and imidazolidinone derivatives as 11B-HSD1 inhibitors for the treatment of diabetes
|
JP2010506915A
(ja)
|
2006-10-20 |
2010-03-04 |
メルク エンド カムパニー インコーポレーテッド |
ナイアシン受容体アゴニスト、そのような化合物を含む組成物、及び治療方法
|
KR100812538B1
(ko)
|
2006-10-23 |
2008-03-11 |
한올제약주식회사 |
약물 제어방출형 메트포르민-글리메피리드 복합제제
|
TW200825063A
(en)
|
2006-10-23 |
2008-06-16 |
Astrazeneca Ab |
Chemical compounds
|
TW200825060A
(en)
|
2006-10-26 |
2008-06-16 |
Astrazeneca Ab |
Chemical compounds
|
US20080103201A1
(en)
|
2006-10-26 |
2008-05-01 |
Wijayabandara Mirihanage Don J |
Novel alpha-Glucosidase inhibitor from Tabernaemontana dichotoma
|
WO2008049711A1
(en)
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Peptide extended insulins
|
WO2008049923A1
(en)
|
2006-10-27 |
2008-05-02 |
Boehringer Ingelheim International Gmbh |
CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
|
EP2079467B1
(en)
|
2006-10-31 |
2015-11-18 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
WO2008054674A2
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
EP2089355A2
(en)
|
2006-11-01 |
2009-08-19 |
Brystol-Myers Squibb Company |
Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof
|
US8198311B2
(en)
|
2006-11-01 |
2012-06-12 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
EP2094692B1
(en)
|
2006-11-01 |
2012-11-28 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
|
US8222247B2
(en)
|
2006-11-01 |
2012-07-17 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-kappabeta activity and use thereof
|
KR101438177B1
(ko)
|
2006-11-01 |
2014-09-05 |
프로노바 바이오파마 너지 에이에스 |
페록시솜 증식자-활성화 수용체의 활성자 또는 조절자인 알파-치환된 오메가-3 지질
|
US7994190B2
(en)
|
2006-11-01 |
2011-08-09 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
EP2077846B1
(en)
|
2006-11-02 |
2011-10-12 |
Piramal Life Sciences Limited |
Benzoxazepine compounds, their preparation and use
|
NZ576750A
(en)
|
2006-11-02 |
2012-01-12 |
Vertex Pharma |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
TW200827346A
(en)
|
2006-11-03 |
2008-07-01 |
Astrazeneca Ab |
Chemical compounds
|
EP1918285A1
(en)
|
2006-11-03 |
2008-05-07 |
Merck Sante |
Diazepane-acetamide derivatives as selective 11beta-HSD1 inhibitors
|
JP2010508371A
(ja)
|
2006-11-06 |
2010-03-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル置換フェニル誘導体、該化合物を含有する医薬品及びその使用と製造方法
|
EP1921080B1
(en)
|
2006-11-07 |
2009-08-05 |
Sanofi-Aventis |
Subsitituted 8-piperidinyl-2-pyridinyl-pyrimido(1,2-a)pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido(1,2-a)pyrimidin-6-one derivatives
|
JP2010043001A
(ja)
|
2006-11-09 |
2010-02-25 |
Sanwa Kagaku Kenkyusho Co Ltd |
Glp−1誘導体とその用途
|
BRPI0718596B8
(pt)
|
2006-11-09 |
2021-05-25 |
Boehringer Ingelheim Int |
composições farmacêuticas para terapia de combinação com inibidores de sglt-2 e metformina
|
US7855206B2
(en)
|
2006-11-14 |
2010-12-21 |
Merck Sharp & Dohme Corp. |
Tricyclic heteroaromatic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
WO2008059866A1
(fr)
|
2006-11-14 |
2008-05-22 |
Santen Pharmaceutical Co., Ltd. |
Nouveau dérivé 1,2-dihydroquinoline comprenant un groupe alkyle inférieur à substitution phénylamino et un groupe phényle dans lequel est introduit un ester en tant que substituants
|
US7750048B2
(en)
|
2006-11-15 |
2010-07-06 |
Janssen Pharmaceutica Nv |
GPR40 agonists
|
WO2008059625A1
(en)
|
2006-11-17 |
2008-05-22 |
National University Corporation Kagawa University |
Utilization of the function of rare sugar as promoter for the migration of glucokinase from nucleus to cytoplasm
|
WO2008062273A2
(en)
|
2006-11-20 |
2008-05-29 |
Cadila Pharmaceuticals Limited |
Solid oral dosage form having antidiabetic drug combination
|
EP2096111A1
(en)
|
2006-11-20 |
2009-09-02 |
Japan Tobacco Inc. |
Pyrazoles and use thereof as drugs
|
EP2086975B1
(en)
|
2006-11-20 |
2012-03-14 |
Bristol-Myers Squibb Company |
7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods
|
WO2008061355A1
(en)
|
2006-11-24 |
2008-05-29 |
Matregen Corp. |
Glp-1 depot systems, and methods of manufacture and uses thereof
|
JP5176964B2
(ja)
|
2006-11-29 |
2013-04-03 |
ユーハ味覚糖株式会社 |
ジペプチジルペプチダーゼiv阻害剤
|
JP4125768B2
(ja)
|
2006-11-30 |
2008-07-30 |
富士産業株式会社 |
α−グルコシダーゼ阻害剤
|
JP5405120B2
(ja)
|
2006-12-01 |
2014-02-05 |
Msd株式会社 |
新規フェニル−イソキサゾール−3−オール誘導体
|
TW200838526A
(en)
|
2006-12-01 |
2008-10-01 |
Astellas Pharma Inc |
Carboxylic acid derivatives
|
JP5455636B2
(ja)
|
2006-12-02 |
2014-03-26 |
ソウル ナショナル ユニバーシティー インダストリー ファンデーション |
アリール化合物、その水和物、その溶媒化物、その立体異性体、または、その薬学的に許容される塩、アリール化合物の製造方法、及び、アリール化合物等の用途
|
UY30730A1
(es)
|
2006-12-04 |
2008-07-03 |
Mitsubishi Tanabe Pharma Corp |
Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
|
NZ577391A
(en)
|
2006-12-04 |
2011-11-25 |
Janssen Pharmaceutica Nv |
Thienyl-containing glycopyranosyl derivatives as antidiabetics
|
AR064106A1
(es)
|
2006-12-05 |
2009-03-11 |
Bayer Schering Pharma Ag |
Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida utiles para el tratamiento de enfermedades y trastornos hiper-proliferativos asociados con la angiogenesis
|
NZ577219A
(en)
|
2006-12-06 |
2011-11-25 |
Smithkline Beecham Corp |
Bicyclic compounds and use as antidiabetics
|
AU2007329548A1
(en)
|
2006-12-06 |
2008-06-12 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE102006058236A1
(de)
|
2006-12-11 |
2008-06-12 |
Merck Patent Gmbh |
Indolizinderivate
|
WO2008071169A2
(de)
|
2006-12-11 |
2008-06-19 |
Universitätsklinikum Schleswig-Holstein |
Verfahren zur herstellung spezifischer inhibitoren der 11beta-hydroxysteroid-dehydrogenase, insbesondere des typs 1, mit nor-oleanan- oder nor-ursan-grundgerüsten
|
EP2112880A4
(en)
|
2006-12-14 |
2011-12-21 |
Merck Sharp & Dohme |
ACYL-BIPIPERIDINYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND PROCESSING METHODS
|
EP2103607A4
(en)
|
2006-12-14 |
2011-01-05 |
Taisho Pharmaceutical Co Ltd |
1-phenyl-1-thio-D-GLUCITOLDERIVAT
|
US7902248B2
(en)
|
2006-12-14 |
2011-03-08 |
Hoffmann-La Roche Inc. |
Oxime glucokinase activators
|
EP1932843A1
(en)
|
2006-12-14 |
2008-06-18 |
sanofi-aventis |
Sulfonyl-phenyl-2H-(1,2,4) oxadiazole-5-one derivatives, processes for their preparation and their use as pharmaceuticals
|
MX2009006631A
(es)
|
2006-12-18 |
2009-06-30 |
Novartis Ag |
Imidazoles como inhibidores de sintasa de aldosterona.
|
RU2009127642A
(ru)
|
2006-12-18 |
2011-01-27 |
Новартис АГ (CH) |
1-замещенные производные имидазола и их применение в качестве ингибиторов альдостеронсинтазы
|
ES2446269T3
(es)
|
2006-12-19 |
2014-03-06 |
The Board Of Trustees Of The University Of Illinois |
3-Benzofuranil-4-indolil-maleimidas como potentes inhibidores de GSK-3 para trastornos neurodegenerativos
|
US8163779B2
(en)
|
2006-12-20 |
2012-04-24 |
Takeda San Diego, Inc. |
Glucokinase activators
|
EP1939187A1
(en)
|
2006-12-20 |
2008-07-02 |
Sanofi-Aventis |
Substituted heteroaryl pyridopyrimidone derivatives
|
US20100029688A1
(en)
|
2006-12-20 |
2010-02-04 |
Wood Harold B |
Bipiperidinyl compounds, compositions containing such compounds and methods of treatment
|
JPWO2008075741A1
(ja)
|
2006-12-20 |
2010-04-15 |
国立大学法人 長崎大学 |
糖尿病治療剤及び予防剤
|
EP1935420A1
(en)
|
2006-12-21 |
2008-06-25 |
Merck Sante |
2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
|
CA2671943A1
(en)
|
2006-12-21 |
2008-07-17 |
Pfizer Products Inc. |
Compounds having both angiotensin ii receptor antagonism and ppary activating activities
|
US20100094009A1
(en)
|
2006-12-21 |
2010-04-15 |
Mccabe James |
Novel crystalline compound useful as glk activator
|
KR20090096636A
(ko)
|
2006-12-22 |
2009-09-11 |
노파르티스 아게 |
Ddp-iv 억제제로서의 1-아미노메틸-l-페닐-시클로헥산 유도체
|
TW200831081A
(en)
|
2006-12-25 |
2008-08-01 |
Kyorin Seiyaku Kk |
Glucokinase activator
|
JP2008156318A
(ja)
|
2006-12-26 |
2008-07-10 |
Dainippon Sumitomo Pharma Co Ltd |
1,3,4−オキサジアゾール−2−オン誘導体
|
TW200835502A
(en)
|
2006-12-26 |
2008-09-01 |
Daiichi Sankyo Co Ltd |
Thiazepine derivatives
|
AU2007343726A1
(en)
|
2006-12-26 |
2008-07-24 |
Amgen Inc. |
N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
|
EP1939192A1
(en)
|
2006-12-28 |
2008-07-02 |
Neuropharma S.A. |
Cyclopentanone derivatives, method of synthesis and uses thereof
|
JP5650404B2
(ja)
|
2006-12-28 |
2015-01-07 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
N−置換−ヘテロシクロアルキルオキシベンズアミド化合物およびその使用方法
|
US7795228B2
(en)
|
2006-12-28 |
2010-09-14 |
Theracos, Inc. |
Spiroheterocyclic glycosides and methods of use
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
EP1939191A1
(en)
|
2006-12-28 |
2008-07-02 |
Neuropharma S.A. |
Furan derivatives, method of synthesis and uses thereof
|
FR2910892A1
(fr)
|
2006-12-29 |
2008-07-04 |
Genfit Sa |
Derives de 1,3-diphenylpropane substitues, preparations et utilisations.
|
FR2910893A1
(fr)
|
2006-12-29 |
2008-07-04 |
Genfit Sa |
Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazolyl)-phenyl-propan-1-one substitues, preparations et utilisations.
|
FR2910894A1
(fr)
|
2006-12-29 |
2008-07-04 |
Genfit Sa |
Derives de 3-phenyl-1-(phenylthienyl)propan-1-one et de 3-phenyl-1-(phenylfuranyl)propan-1-one substitues, preparation et utilisation.
|
JP5296555B2
(ja)
|
2007-01-03 |
2013-09-25 |
タカノ株式会社 |
環状スルホニウム塩の製造方法
|
AR064735A1
(es)
|
2007-01-04 |
2009-04-22 |
Prosidion Ltd |
Agonistas de gpcr y composicion farmaceutica en base al compuesto
|
GB0700122D0
(en)
|
2007-01-04 |
2007-02-14 |
Prosidion Ltd |
GPCR agonists
|
US20100048632A1
(en)
|
2007-01-04 |
2010-02-25 |
Matthew Colin Thor Fyfe |
Piperidine GPCR Agonists
|
CL2008000017A1
(es)
|
2007-01-04 |
2008-08-01 |
Prosidion Ltd |
Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci
|
BRPI0806312A2
(pt)
|
2007-01-04 |
2011-09-06 |
Prosidion Ltd |
agonistas cgpr piperidina
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
FR2911137B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2,4-dianilinopyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
US20090098130A1
(en)
|
2007-01-05 |
2009-04-16 |
Bradshaw Curt W |
Glucagon-like protein-1 receptor (glp-1r) agonist compounds
|
JP2008169195A
(ja)
|
2007-01-05 |
2008-07-24 |
Hanmi Pharmaceutical Co Ltd |
キャリア物質を用いたインスリン分泌ペプチド薬物結合体
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
EP2104666A4
(en)
|
2007-01-08 |
2011-05-25 |
Seoul Nat Univ Ind Foundation |
THIAZOL COMPOUND (AS PPAR DELTA LIGAND), AND PHARMACEUTICAL, COSMETIC AND HEALTHY FOOD THEREOF
|
JP2010515701A
(ja)
|
2007-01-09 |
2010-05-13 |
ノボ・ノルデイスク・エー/エス |
ウレアグルコキナーゼアクチベーター
|
JP5207981B2
(ja)
|
2007-01-10 |
2013-06-12 |
田辺三菱製薬株式会社 |
ヒドラゾン誘導体
|
WO2008084873A1
(ja)
|
2007-01-10 |
2008-07-17 |
Mitsubishi Tanabe Pharma Corporation |
オキシム誘導体
|
JP4328820B2
(ja)
|
2007-01-10 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
US8318778B2
(en)
|
2007-01-11 |
2012-11-27 |
Novo Nordisk A/S |
Urea glucokinase activators
|
KR100848491B1
(ko)
|
2007-01-16 |
2008-07-28 |
영진약품공업주식회사 |
베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
|
DE102007002260A1
(de)
|
2007-01-16 |
2008-07-31 |
Sanofi-Aventis |
Verwendung von substituierten Pyranonsäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms
|
WO2008087654A2
(en)
|
2007-01-16 |
2008-07-24 |
Cadila Healthcare Limited |
PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1
|
WO2008089463A2
(en)
|
2007-01-18 |
2008-07-24 |
Evolva Sa |
Substituted 1,3-dioxanes and their uses
|
DE102007002717A1
(de)
|
2007-01-18 |
2008-07-24 |
Merck Patent Gmbh |
Heterocyclische Indazolderivate
|
MX2009007668A
(es)
|
2007-01-18 |
2011-12-08 |
Evolva Sa |
1,3-dioxanos sustituidos y sus usos.
|
WO2008088006A1
(ja)
|
2007-01-19 |
2008-07-24 |
Shinji Yokoyama |
Ap2抑制剤
|
WO2008091863A1
(en)
|
2007-01-23 |
2008-07-31 |
Kalypsys, Inc. |
Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
|
WO2008091338A1
(en)
|
2007-01-23 |
2008-07-31 |
Reddy Us Therapeutics, Inc. |
Methods and compositions for the treatment of insulin resistance, diabetes, and diabetes-associated dyslipidemia
|
CN101230058A
(zh)
|
2007-01-23 |
2008-07-30 |
上海恒瑞医药有限公司 |
双环氮杂烷类衍生物、其制备方法及其在医药上的用途
|
US8431713B2
(en)
|
2007-01-24 |
2013-04-30 |
Array Biopharma, Inc. |
2-aminopyridine derivatives as glucokinase activators
|
TW200838549A
(en)
|
2007-01-26 |
2008-10-01 |
Boehringer Ingelheim Int |
Methods for preventing and treating neurodegenerative disorders
|
WO2008089892A1
(de)
|
2007-01-26 |
2008-07-31 |
Sanofi-Aventis |
Phenothiazin derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
AR065034A1
(es)
|
2007-01-26 |
2009-05-13 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos neurodegenerativos
|
RU2462469C2
(ru)
|
2007-01-26 |
2012-09-27 |
Канек Фарма Инк. |
Конденсированные ароматические дифторметанфосфонаты в качестве ингибиторов протеинтирозинфосфатазы ib (ptp-1b)
|
EP2128138A1
(en)
|
2007-01-29 |
2009-12-02 |
Takeda Pharmaceutical Company Limited |
Pyrazole compound
|
KR20080071476A
(ko)
|
2007-01-30 |
2008-08-04 |
주식회사 엘지생명과학 |
신규한 디펩티딜 펩티데이즈 iv(dpp-iv) 저해제
|
NZ578744A
(en)
|
2007-01-31 |
2012-02-24 |
Vertex Pharma |
2-aminopyridine derivatives useful as kinase inhibitors
|
WO2008096820A1
(ja)
|
2007-02-07 |
2008-08-14 |
Kyowa Hakko Kirin Co., Ltd. |
ビフェニル誘導体
|
KR101126383B1
(ko)
|
2007-02-07 |
2012-04-12 |
교와 핫꼬 기린 가부시키가이샤 |
3환계 화합물
|
NZ578876A
(en)
|
2007-02-07 |
2012-12-21 |
Pfizer |
3-amino-pyrrolo[3,4-c]pyrazole-5 (1h, 4h, 6h) carbaldehyde derivatives as pkc inhibitors
|
WO2008097535A2
(en)
|
2007-02-08 |
2008-08-14 |
Merck & Co., Inc. |
Method of treating atherosclerosis, dyslipidemias and related conditions
|
WO2008096769A1
(ja)
|
2007-02-08 |
2008-08-14 |
Daiichi Sankyo Company, Limited |
置換されたセルコスポラミド誘導体を含有する医薬
|
TW201336497A
(zh)
|
2007-02-08 |
2013-09-16 |
Daiichi Sankyo Co Ltd |
噻唑啶二酮化合物之結晶型及其製法
|
CA2894112C
(en)
|
2007-02-09 |
2020-09-15 |
Metabasis Therapeutics, Inc. |
Novel antagonists of the glucagon receptor
|
TW200838515A
(en)
|
2007-02-09 |
2008-10-01 |
Takeda Pharmaceutical |
Fused ring compound
|
JP2010120851A
(ja)
|
2007-02-09 |
2010-06-03 |
Kyorin Pharmaceut Co Ltd |
二量化シクロ誘導体
|
WO2008099448A1
(ja)
|
2007-02-09 |
2008-08-21 |
Masayoshi Yamaguchi |
糖尿病性疾患の予防・治療剤
|
TW200836719A
(en)
|
2007-02-12 |
2008-09-16 |
Astrazeneca Ab |
Chemical compounds
|
GEP20135944B
(en)
|
2007-02-15 |
2013-10-25 |
Indiana Unversity Research And Tech Corporation |
Glucagon/glp-1 receptor co-agonists
|
DE102007007751A1
(de)
|
2007-02-16 |
2008-08-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE102007008420A1
(de)
|
2007-02-21 |
2008-08-28 |
Merck Patent Gmbh |
Benzimidazolderivate
|
EP2125768A1
(en)
|
2007-02-21 |
2009-12-02 |
Boehringer Ingelheim International GmbH |
Tetrasubstituted glucopyranosylated benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
CN101646660A
(zh)
|
2007-02-22 |
2010-02-10 |
Irm责任有限公司 |
调节g蛋白偶联受体的化合物和方法
|
EP1961742A1
(en)
|
2007-02-22 |
2008-08-27 |
Novartis AG |
compounds of formula (I) as serine protease inhibitors
|
BRPI0807637A2
(pt)
|
2007-02-22 |
2014-06-03 |
Irm Llc |
Derivados de tiazol como moduladores de receptores acoplados à proteína g
|
WO2008101886A1
(en)
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
MX2009008228A
(es)
|
2007-02-23 |
2009-08-12 |
High Point Pharmaceuticals Llc |
N-adamantil benzamidas como inhibidores de la dehidrogenasa 11-beta-hidroxiesteroide.
|
WO2008101907A2
(en)
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
US20110003852A1
(en)
|
2007-02-23 |
2011-01-06 |
Soren Ebdrup |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
US8835426B2
(en)
|
2007-02-26 |
2014-09-16 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
DE102007009494A1
(de)
|
2007-02-27 |
2008-08-28 |
Bayer Healthcare Ag |
Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung
|
EP2125735B1
(en)
|
2007-02-28 |
2012-06-27 |
Advinus Therapeutics Private Limited |
2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
|
WO2008109334A1
(en)
|
2007-03-02 |
2008-09-12 |
Merck & Co., Inc. |
Novel crystalline salt form of an antidiabetic compound
|
WO2008108602A1
(en)
|
2007-03-07 |
2008-09-12 |
Dong-A Pharm. Co., Ltd. |
Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same
|
CN101687800B
(zh)
|
2007-03-07 |
2012-03-21 |
杏林制药株式会社 |
葡糖激酶活化物质
|
MX2009009290A
(es)
|
2007-03-08 |
2009-09-10 |
Plexxikon Inc |
Compuestos activos en ppar.
|
WO2008109702A1
(en)
|
2007-03-08 |
2008-09-12 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
EP2125711B1
(en)
|
2007-03-08 |
2013-11-06 |
Albireo Ab |
3-phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease
|
PE20090159A1
(es)
|
2007-03-08 |
2009-02-21 |
Plexxikon Inc |
COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
|
EA200970841A1
(ru)
|
2007-03-09 |
2010-04-30 |
ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Фармацевтическое применение замещенных амидов
|
ES2435997T3
(es)
|
2007-03-09 |
2013-12-26 |
Vertex Pharmaceuticals, Inc. |
Aminopirimidinas útiles como inhibidores de las proteínas cinasas
|
AU2008226466B2
(en)
|
2007-03-09 |
2013-06-13 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
CN101260103A
(zh)
|
2007-03-09 |
2008-09-10 |
上海艾力斯医药科技有限公司 |
一类具有部分PPARγ激动剂活性的化合物及其应用
|
WO2008112939A2
(en)
|
2007-03-13 |
2008-09-18 |
Board Of Regents, The University Of Texas System |
Composition and method for making oligo-benzamide compounds
|
DE102007012284A1
(de)
|
2007-03-16 |
2008-09-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE102007012645A1
(de)
|
2007-03-16 |
2008-09-18 |
Bayer Healthcare Ag |
Substituierte Imidazo- und Triazolopyrimidine
|
EP1972349A1
(en)
|
2007-03-21 |
2008-09-24 |
Biocompatibles UK Limited |
GLP-1 fusion peptides conjugated to polymer(s), their production and use
|
US8173645B2
(en)
|
2007-03-21 |
2012-05-08 |
Takeda San Diego, Inc. |
Glucokinase activators
|
AR065809A1
(es)
|
2007-03-22 |
2009-07-01 |
Bristol Myers Squibb Co |
Formulaciones farmaceuticas que contienen un inhibidor sglt2
|
TW200904454A
(en)
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Methods for treating obesity employing an SGLT2 inhibitor and compositions thereof
|
CN101641358A
(zh)
|
2007-03-23 |
2010-02-03 |
霍夫曼-拉罗奇有限公司 |
氮杂-吡啶并嘧啶酮衍生物
|
JP5450108B2
(ja)
|
2007-03-23 |
2014-03-26 |
アレイ バイオファーマ、インコーポレイテッド |
グルコキナーゼ活性化剤としての2−アミノピリジン類似体
|
WO2008116294A1
(en)
|
2007-03-23 |
2008-10-02 |
Matregen Corp. |
Exendin analogs
|
US20100105629A1
(en)
|
2007-03-23 |
2010-04-29 |
Bachovchin William W |
N-Substituted Peptidomimetic Inhibitors of Dipeptidylpeptidase IV
|
WO2008119005A1
(en)
|
2007-03-27 |
2008-10-02 |
Trustees Of Tufts College |
3,4-dehydro-proline-containing inhibitors of dipeptidylpeptidase iv
|
EP1975176A1
(en)
|
2007-03-27 |
2008-10-01 |
Biocompatibles UK Limited |
Novel glp-1 fusion peptides, their production and use
|
JP2010522766A
(ja)
|
2007-03-28 |
2010-07-08 |
ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー |
11ベータ−hsd1活性化合物
|
WO2008117982A1
(en)
|
2007-03-28 |
2008-10-02 |
Crystal Genomics, Inc. |
Heterocyclic carboxylic acid derivatives and pharmaceutical composition for inhibiting lipid accumulation containing same
|
JP2010522732A
(ja)
|
2007-03-29 |
2010-07-08 |
ナームローゼ・フエンノートチヤツプ・オルガノン |
鉱質コルチコイド受容体アンタゴニスト
|
WO2008121064A1
(en)
|
2007-03-30 |
2008-10-09 |
Astrazeneca Ab |
New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705
|
US7998992B2
(en)
|
2007-03-30 |
2011-08-16 |
Institute Of Medicinal Molecular Design, Inc. |
Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1
|
JP2010138073A
(ja)
|
2007-03-30 |
2010-06-24 |
Taisho Pharmaceutical Co Ltd |
ピコリン酸アミド化合物
|
CA2682715A1
(en)
|
2007-03-30 |
2008-10-09 |
Astrazeneca Ab |
New imidazo[4,5-b]pyridine-7-carboxamides 704
|
CN101274918A
(zh)
|
2007-03-30 |
2008-10-01 |
中国科学院上海药物研究所 |
一类取代五元杂环化合物,其制备方法和医学用途
|
US8133898B2
(en)
|
2007-03-30 |
2012-03-13 |
Takeda Pharmaceutical Company Limited |
Renin inhibitors
|
ES2466672T3
(es)
|
2007-04-02 |
2014-06-10 |
Theracos, Inc. |
Derivados de glicósido bencílico y métodos de uso
|
CN101279955B
(zh)
|
2007-04-03 |
2012-11-28 |
北京摩力克科技有限公司 |
作为二肽肽激酶-iv抑制剂的n-取代硫吗啉衍生物及其医药用途
|
WO2008120813A1
(ja)
|
2007-04-03 |
2008-10-09 |
Mitsubishi Tanabe Pharma Corporation |
ジペプチジルペプチダーゼ4阻害化合物と甘味料との併用
|
JP5294419B2
(ja)
|
2007-04-05 |
2013-09-18 |
第一三共株式会社 |
縮合二環式ヘテロアリール誘導体
|
AU2008235066A1
(en)
|
2007-04-05 |
2008-10-16 |
Sanofi-Aventis |
Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
|
WO2008126731A1
(ja)
|
2007-04-05 |
2008-10-23 |
Daiichi Sankyo Company, Limited |
アリール誘導体
|
WO2008122357A1
(de)
|
2007-04-05 |
2008-10-16 |
Sanofi-Aventis |
5-oxo-isoxazole als inhibitoren von lipasen und phospholipasen
|
CA2683647A1
(en)
|
2007-04-10 |
2008-10-16 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
EP2136811A1
(en)
|
2007-04-10 |
2009-12-30 |
Boehringer Ingelheim International GmbH |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
EP2152081B1
(en)
|
2007-04-11 |
2012-10-24 |
High Point Pharmaceuticals, LLC |
Novel compounds
|
CA2683624A1
(en)
|
2007-04-12 |
2008-10-23 |
F. Hoffmann-La Roche Ag |
Pharmaceutical compounds
|
GB0707087D0
(en)
|
2007-04-12 |
2007-05-23 |
Piramed Ltd |
Pharmaceutical compounds
|
US8114871B2
(en)
|
2007-04-12 |
2012-02-14 |
Pfizer Inc. |
3-amido-pyrrolo[3,4-C]pyrazole-5(1H,4H,6H) carbaldehyde derivatives
|
MX2009010881A
(es)
|
2007-04-12 |
2009-12-14 |
Hoffmann La Roche |
Compuestos farmaceuticos.
|
CN101679445A
(zh)
|
2007-04-13 |
2010-03-24 |
先灵公司 |
嘧啶二酮衍生物及其应用
|
EP2139843B1
(en)
|
2007-04-16 |
2013-12-25 |
Amgen, Inc |
Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
|
US8546394B2
(en)
|
2007-04-17 |
2013-10-01 |
Bristol-Myers Squibb Company |
Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors
|
MX2009010890A
(es)
|
2007-04-18 |
2009-10-26 |
Astrazeneca Ab |
Nuevo proceso para la fabricacion del compuesto de 2-hidroxi-3-[5-(morfolin-4-ilmetil)piridin-2-il]1h-indol-5-carbon itrilo 701.
|
JP5148686B2
(ja)
|
2007-04-19 |
2013-02-20 |
ドン・ア・ファーム・カンパニー・リミテッド |
β−アミノ基を含むDPP−IV阻害剤、その製造方法及びそれを有効成分として含む糖尿または肥満予防及び治療用医薬組成物
|
CN101754961A
(zh)
|
2007-04-20 |
2010-06-23 |
先灵公司 |
嘧啶酮衍生物及其使用方法
|
CN102015677A
(zh)
|
2007-04-20 |
2011-04-13 |
先灵公司 |
嘧啶酮衍生物及其使用方法
|
CN101686980A
(zh)
|
2007-04-20 |
2010-03-31 |
先灵公司 |
四氢吡啶并[4,3-d]嘧啶酮衍生物及其使用方法
|
PE20090696A1
(es)
|
2007-04-20 |
2009-06-20 |
Bristol Myers Squibb Co |
Formas cristalinas de saxagliptina y procesos para preparar las mismas
|
WO2008134221A1
(en)
|
2007-04-24 |
2008-11-06 |
High Point Pharmaceuticals, Llc |
Pharmaceutical use of substituted amides
|
US20100274022A1
(en)
|
2007-04-26 |
2010-10-28 |
Pharmafrontier Co., Ltd. |
G protein-coupled receptor inhibitor and pharmaceutical product
|
JP2010159210A
(ja)
|
2007-04-26 |
2010-07-22 |
Dainippon Sumitomo Pharma Co Ltd |
縮合複素環誘導体
|
WO2008136393A1
(ja)
|
2007-04-27 |
2008-11-13 |
Ajinomoto Co., Inc. |
ラクタム化合物の結晶形およびその製造方法
|
US8318746B2
(en)
|
2007-04-27 |
2012-11-27 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing five-membered heterocyclic compound
|
WO2008137436A1
(en)
|
2007-05-04 |
2008-11-13 |
Bristol-Myers Squibb Company |
[6,5]-bicyclic gpr119 g protein-coupled receptor agonists
|
CN101668756A
(zh)
|
2007-05-04 |
2010-03-10 |
百时美施贵宝公司 |
[6,6]和[6,7]-双环gpr119 g蛋白偶合受体激动剂
|
WO2008137105A1
(en)
|
2007-05-07 |
2008-11-13 |
Merck & Co., Inc. |
Method of treatment using fused aromatic compounds having anti-diabetic activity
|
KR20080099174A
(ko)
|
2007-05-07 |
2008-11-12 |
주식회사 머젠스 |
비만, 당뇨, 대사성 질환, 퇴행성 질환 및 미토콘드리아이상 질환의 치료 또는 예방을 위한 나프토퀴논계 약제조성물
|
DE102007022565A1
(de)
|
2007-05-14 |
2008-11-20 |
Merck Patent Gmbh |
Heterocyclische Indazolderivate
|
EP1992624A1
(en)
|
2007-05-16 |
2008-11-19 |
Sanofi-Aventis |
Heteroarylamide pyrimidone compounds
|
EP1992621A1
(en)
|
2007-05-16 |
2008-11-19 |
Sanofi-Aventis |
Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
|
EP1992625A1
(en)
|
2007-05-16 |
2008-11-19 |
Sanofi-Aventis |
Arylamide pyrimidone compounds
|
EP1992620A1
(en)
|
2007-05-16 |
2008-11-19 |
Sanofi-Aventis |
Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases
|
US8236855B2
(en)
|
2007-05-17 |
2012-08-07 |
Case Western Reserve University |
Methods of treating metabolic disorders
|
CN103288738B
(zh)
|
2007-05-18 |
2016-03-16 |
盐野义制药株式会社 |
具有11β-羟基类固醇脱氢酶I型抑制活性的含氮杂环衍生物
|
WO2008142859A1
(ja)
|
2007-05-18 |
2008-11-27 |
Kowa Company, Ltd. |
新規なスピロオキシインドール化合物及びこれを含有する医薬
|
WO2008144346A2
(en)
|
2007-05-18 |
2008-11-27 |
Bristol-Myers Squibb Company |
Crystal structures of sglt2 inhibitors and processes for their preparation
|
CN101679317B
(zh)
|
2007-05-29 |
2012-10-31 |
参天制药株式会社 |
具有糖皮质激素受体结合活性且具有导入了磺酸酯或磺酰胺结构的苯基作为取代基的1,2,3,4-四氢喹喔啉衍生物
|
WO2008145721A2
(en)
|
2007-06-01 |
2008-12-04 |
Novo Nordisk A/S |
N-terminal modification of polypeptides for protection against degradation by aminopeptidases
|
US7829664B2
(en)
|
2007-06-01 |
2010-11-09 |
Boehringer Ingelheim International Gmbh |
Modified nucleotide sequence encoding glucagon-like peptide-1 (GLP-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (GLP-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof
|
AR066820A1
(es)
|
2007-06-04 |
2009-09-16 |
Novartis Ag |
Compuestos de tiadiazolidin-3 ona
|
EP2155720B1
(en)
|
2007-06-08 |
2013-07-17 |
Advinus Therapeutics Private Limited |
Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
|
WO2008148839A2
(en)
|
2007-06-08 |
2008-12-11 |
Ascendis Pharma As |
Long-acting polymeric prodrugs of exendin
|
US8222285B2
(en)
|
2007-06-11 |
2012-07-17 |
Bristol-Myers Squibb Company |
1,3-dihydroxy substituted phenylamide glucokinase activators
|
ATE520714T1
(de)
|
2007-06-15 |
2011-09-15 |
Zealand Pharma As |
Glucagonanaloga
|
WO2008156757A1
(en)
|
2007-06-19 |
2008-12-24 |
Takeda Pharmaceutical Company Limited |
Indazole compounds for activating glucokinase
|
JPWO2008156174A1
(ja)
|
2007-06-21 |
2010-08-26 |
大正製薬株式会社 |
ピラジンアミド化合物
|
CL2008001839A1
(es)
|
2007-06-21 |
2009-01-16 |
Incyte Holdings Corp |
Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
|
EP2172453A4
(en)
|
2007-06-27 |
2010-12-22 |
Taisho Pharmaceutical Co Ltd |
COMPOUND HAVING 11 ß-HSD1 INHIBITION ACTIVITY
|
AU2008267724A1
(en)
|
2007-06-28 |
2008-12-31 |
Merck Frosst Canada Ltd |
Substituted fused pyrimidines as antagonists of GPR105 activity
|
WO2009005672A1
(en)
|
2007-06-29 |
2009-01-08 |
Merck & Co., Inc. |
Antidiabetic azaindoles and diazaindoles
|
WO2009003681A1
(en)
|
2007-07-02 |
2009-01-08 |
Santhera Pharmaceuticals (Schweiz) Ag |
Dpp-iv inhibitors
|
US20100279930A1
(en)
|
2007-07-09 |
2010-11-04 |
Stephen Robert Bloom |
Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour
|
DE102007032349A1
(de)
|
2007-07-11 |
2009-01-15 |
Bayer Healthcare Ag |
Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung
|
EP2178821A2
(en)
|
2007-07-12 |
2010-04-28 |
Deviris Inc. |
Hormone sensitive lipase modulators and methods of use
|
WO2009012039A2
(en)
|
2007-07-13 |
2009-01-22 |
Metabasis Therapeutics Inc. |
Crystalline polymorphs
|
BRPI0815097A2
(pt)
|
2007-07-17 |
2018-07-24 |
Bristol-Myers Squibb Company |
agonistas de receptor acoplado à proteína g gpr119 de piridona
|
RU2440989C2
(ru)
|
2007-07-17 |
2012-01-27 |
Ф.Хоффманн-Ля Рош Аг |
ИНГИБИТОРЫ 11β-ГИДРОКСИСТЕРОИДНОЙ ДЕГИДРОГЕНАЗЫ
|
EA201000130A1
(ru)
|
2007-07-18 |
2010-08-30 |
Новартис Аг |
Бициклические гетероарильные соединения и их применение в качестве ингибиторов киназы
|
EP2185544B1
(en)
|
2007-07-19 |
2014-11-26 |
Cymabay Therapeutics, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 for the treatment of diabetes and metabolic disorders
|
JP5215607B2
(ja)
|
2007-07-23 |
2013-06-19 |
シーシーアイ株式会社 |
ペルオキシゾーム増殖剤応答性受容体(PPAR)αリガンド剤
|
WO2009014676A1
(en)
|
2007-07-23 |
2009-01-29 |
Merck & Co., Inc. |
Novel crystalline form of a dihydrochloride salt of a dipeptidyl peptidase-iv inhibitor
|
US8759355B2
(en)
|
2007-07-25 |
2014-06-24 |
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. |
Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof
|
WO2009015067A2
(en)
|
2007-07-25 |
2009-01-29 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
ES2395081T3
(es)
|
2007-07-26 |
2013-02-08 |
Vitae Pharmaceuticals, Inc. |
Síntesis de inhibidores de la 11beta-hidroxiesteroide deshidrogenasa de tipo 1
|
DE102007035334A1
(de)
|
2007-07-27 |
2009-01-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE102007035333A1
(de)
|
2007-07-27 |
2009-01-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
|
JP2010534722A
(ja)
|
2007-07-27 |
2010-11-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
新規グルコキナーゼ活性化薬およびその使用方法
|
WO2009017452A1
(en)
|
2007-07-30 |
2009-02-05 |
Astrazeneca Ab |
New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate
|
WO2009019600A2
(en)
|
2007-08-03 |
2009-02-12 |
Dr. Reddy's Laboratories Ltd. |
Modulation of endogenous ampk levels for the treatment of obesity
|
EP2020232A1
(en)
|
2007-08-03 |
2009-02-04 |
Zeltia, S.A. |
N-(1-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
|
WO2009019446A1
(en)
|
2007-08-03 |
2009-02-12 |
Betagenon Ab |
Compounds useful as medicaments
|
WO2009020140A1
(ja)
|
2007-08-06 |
2009-02-12 |
Dainippon Sumitomo Pharma Co., Ltd. |
アダマンチルウレア誘導体
|
FR2919869B1
(fr)
|
2007-08-09 |
2009-09-25 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
JP5572549B2
(ja)
|
2007-08-13 |
2014-08-13 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
グルコキナーゼの新規な活性化剤
|
CA2696285A1
(en)
|
2007-08-15 |
2009-02-19 |
Schering Corporation |
Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1
|
EP2188293B1
(en)
|
2007-08-15 |
2019-05-01 |
Merck Sharp & Dohme Corp. |
6-substituted sulfonyl azabicycloý3.2.1¨octanes useful to inhibit 11 -hydroxysteroid dehydrogenase type-1
|
CA2696336A1
(en)
|
2007-08-15 |
2009-02-19 |
Schering Corporation |
Substituted azepine- and diazepine-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1
|
WO2009026345A1
(en)
|
2007-08-20 |
2009-02-26 |
Targegen Inc. |
Thiazolidinone compounds, and methods of making and using same
|
CA2696211C
(en)
|
2007-08-21 |
2015-05-26 |
Merck Sharp & Dohme Corp. |
Heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
JP5736098B2
(ja)
|
2007-08-21 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
中枢神経系障害を治療するための医薬組成物
|
RS56822B1
(sr)
|
2007-08-23 |
2018-04-30 |
Theracos Sub Llc |
Derivati (2s,3r,4r,5s,6r)-2-(4-hloro-3-benzilfenil)-6-(hidroksimetil)tetrahidro-2h- piran-3,4,5-triola za upotrebu za lečenje dijabetesa
|
WO2009026658A1
(en)
|
2007-08-29 |
2009-03-05 |
The University Of Sydney |
Ppar agonists
|
WO2009026657A1
(en)
|
2007-08-29 |
2009-03-05 |
The University Of Sydney |
Flavonoid ppar agonists
|
US20090105480A1
(en)
|
2007-08-30 |
2009-04-23 |
Ulrike Bromberger |
Process for the preparation of a dpp-iv inhibitor
|
KR101085157B1
(ko)
|
2007-08-31 |
2011-11-18 |
한국화학연구원 |
1,3,5-트리아진-2,4,6-트리아민 화합물 또는 그의 약학적으로 허용 가능한 염, 및 이를 포함하는 약학적 조성물
|
US20090062369A1
(en)
|
2007-08-31 |
2009-03-05 |
Joaquim Trias |
Use of secretory phospholipase a2 (spla2) inhibitors to decrease spla2 levels
|
ES2532116T3
(es)
|
2007-09-05 |
2015-03-24 |
Novo Nordisk A/S |
Péptidos derivados con A-B-C-D y sus usos terapéuticos
|
CN101868476B
(zh)
|
2007-09-05 |
2015-02-25 |
诺沃-诺迪斯克有限公司 |
胰高血糖素样肽-1衍生物及其制药用途
|
DE102007042154A1
(de)
|
2007-09-05 |
2009-03-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
|
CN101842386A
(zh)
|
2007-09-05 |
2010-09-22 |
诺沃-诺迪斯克有限公司 |
截短的glp-1衍生物和它们的治疗用途
|
JP2010538072A
(ja)
|
2007-09-06 |
2010-12-09 |
ジェナエラ コーポレイション |
糖尿病を治療する方法
|
DE102007042754A1
(de)
|
2007-09-07 |
2009-03-12 |
Bayer Healthcare Ag |
Substituierte 6-Phenylnikotinsäuren und ihre Verwendung
|
EP2650006A1
(en)
|
2007-09-07 |
2013-10-16 |
Ipsen Pharma S.A.S. |
Analogues of exendin-4 and exendin-3
|
JP2010539152A
(ja)
|
2007-09-10 |
2010-12-16 |
プロシディオン・リミテッド |
代謝障害の治療のための化合物
|
EP2036923A1
(en)
|
2007-09-11 |
2009-03-18 |
Novo Nordisk A/S |
Improved derivates of amylin
|
US20100222251A1
(en)
|
2007-09-11 |
2010-09-02 |
Novo Nordisk A/S |
Mixture comprising an amylin peptide and a protracted insulin
|
ATE531721T1
(de)
|
2007-09-11 |
2011-11-15 |
Kyorin Seiyaku Kk |
Cyanoaminochinolone als gsk-3-inhibitoren
|
US8476261B2
(en)
|
2007-09-12 |
2013-07-02 |
Kyorin Pharmaceutical Co., Ltd. |
Spirocyclic aminoquinolones as GSK-3 inhibitors
|
US7659313B2
(en)
|
2007-09-13 |
2010-02-09 |
Gateway Health Alliances, Inc. |
Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
|
PL2203433T3
(pl)
|
2007-09-14 |
2013-04-30 |
Metabolic Solutions Dev Co Llc |
5-(4-(2-(3-metoksyfenylo)-2-oksoetoksy)benzylo)tiazolidyno-2,4-dion do stosowania w leczeniu cukrzycy
|
WO2009038204A1
(ja)
|
2007-09-17 |
2009-03-26 |
Pharma Frontier Co., Ltd. |
新規長鎖脂肪酸誘導体化合物及びそれら化合物を有効成分とするgタンパク質共役型レセプター作動剤
|
WO2009038064A1
(ja)
|
2007-09-19 |
2009-03-26 |
Institute Of Medicinal Molecular Design, Inc. |
I型11βヒドロキシステロイド脱水素酵素阻害活性を有する複素環誘導体
|
ES2499018T3
(es)
|
2007-09-20 |
2014-09-26 |
Irm Llc |
Compuestos y composiciones como moduladores de la actividad de GPR119
|
JP5427784B2
(ja)
|
2007-09-21 |
2014-02-26 |
サノフイ |
(カルボキシルアルキレン−フェニル)−フェニル−オキサルアミド、その製造方法、及び薬剤としてのその使用
|
GB2465132B
(en)
|
2007-09-21 |
2012-06-06 |
Lupin Ltd |
Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors
|
EA019104B1
(ru)
|
2007-09-21 |
2014-01-30 |
Эррей Биофарма Инк. |
Активаторы глюкокиназы
|
WO2009039942A1
(de)
|
2007-09-21 |
2009-04-02 |
Sanofi-Aventis |
(cyclopropyl-phenyl)-phenyl-oxalamide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
KR20090031122A
(ko)
|
2007-09-21 |
2009-03-25 |
주식회사 중외제약 |
인다졸 골격을 함유하는 화합물, 이의 제조방법 및 상기화합물을 함유하는 약제학적 조성물
|
EP2203448B1
(de)
|
2007-09-21 |
2011-06-22 |
Sanofi-Aventis |
Phenothiazin-derivate mit doppelbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
US8143280B2
(en)
|
2007-09-27 |
2012-03-27 |
Hoffmann-La Roche Inc. |
Glucocorticoid receptor antagonists
|
EP2195287A1
(en)
|
2007-09-28 |
2010-06-16 |
GlaxoSmithKline LLC |
Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
|
CA2701020A1
(en)
|
2007-09-28 |
2009-04-09 |
Glaxosmithkline Llc |
Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
AU2008310519B2
(en)
|
2007-10-08 |
2013-05-02 |
Advinus Therapeutics Private Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
KR20100090250A
(ko)
|
2007-10-09 |
2010-08-13 |
메르크 파텐트 게엠베하 |
글루코키나제 활성체로서 유용한 피리딘 유도체
|
PT2197849E
(pt)
|
2007-10-09 |
2013-04-23 |
Merck Patent Gmbh |
Derivados de n-(pirazole-3-il)-benzamida como ativadores de glucoquinase
|
WO2009047240A1
(en)
|
2007-10-09 |
2009-04-16 |
Smithkline Beecham Corporation |
Indole derivatives useful as ppar activators
|
US8030354B2
(en)
|
2007-10-10 |
2011-10-04 |
Amgen Inc. |
Substituted biphenyl GPR40 modulators
|
CN101821243B
(zh)
|
2007-10-11 |
2013-05-08 |
中国科学院上海药物研究所 |
一类嘧啶取代苯丙酸衍生物及其作为ppar激动剂的用途
|
DE102007048716A1
(de)
|
2007-10-11 |
2009-04-23 |
Merck Patent Gmbh |
Imidazo[1,2-a]pyrimidinderivate
|
WO2009049222A1
(en)
|
2007-10-12 |
2009-04-16 |
Curedm, Inc. |
Compositions and methods of using the human proislet peptide receptor
|
GB0720389D0
(en)
|
2007-10-18 |
2008-11-12 |
Prosidion Ltd |
G-Protein Coupled Receptor Agonists
|
GB0720390D0
(en)
|
2007-10-18 |
2007-11-28 |
Prosidion Ltd |
G-Protein coupled receptor agonists
|
US8907095B2
(en)
|
2007-10-22 |
2014-12-09 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
|
CN101417999A
(zh)
|
2007-10-25 |
2009-04-29 |
上海恒瑞医药有限公司 |
哌嗪类衍生物,其制备方法及其在医药上的应用
|
WO2009054479A1
(ja)
|
2007-10-26 |
2009-04-30 |
Japan Tobacco Inc. |
スピロ環化合物及びその医薬用途
|
WO2009056881A1
(en)
|
2007-10-29 |
2009-05-07 |
Astrazeneca Ab |
Chemical compounds 313
|
US8399507B2
(en)
|
2007-10-29 |
2013-03-19 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
EP2217701B9
(en)
|
2007-10-30 |
2015-02-18 |
Indiana University Research and Technology Corporation |
Glucagon antagonists
|
CA2702289A1
(en)
|
2007-10-30 |
2009-05-07 |
Indiana University Research And Technology Corporation |
Compounds exhibiting glucagon antagonist and glp-1 agonist activity
|
WO2009057784A1
(ja)
|
2007-11-01 |
2009-05-07 |
Takeda Pharmaceutical Company Limited |
複素環化合物
|
CA2704803C
(en)
|
2007-11-05 |
2017-04-11 |
Denis Carniato |
7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
AR069207A1
(es)
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
US8710000B2
(en)
|
2007-11-08 |
2014-04-29 |
Novo Nordisk A/S |
Insulin derivative
|
US8232284B2
(en)
|
2007-11-12 |
2012-07-31 |
Msd K. K. |
Heteroaryloxy quinazoline derivative
|
EP2058308A1
(fr)
|
2007-11-12 |
2009-05-13 |
Merck Sante |
Dérivés de benzimidazoledihydrothiadiazinone comme inhibiteurs de fructose-1,6-biphosphatase et compositions pharmaceutiques les contenant.
|
TW200927115A
(en)
|
2007-11-16 |
2009-07-01 |
Boehringer Ingelheim Int |
Aryl-and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
|
WO2009065131A1
(en)
|
2007-11-16 |
2009-05-22 |
Rigel Pharmaceuticals, Inc. |
Carboxamide, sulfonamide and amine compounds for metabolic disorders
|
US20090221595A1
(en)
|
2007-11-26 |
2009-09-03 |
Nurit Perlman |
Crystalline form of sitagliptin
|
WO2009070497A1
(en)
|
2007-11-28 |
2009-06-04 |
Smithkline Beecham Corporation |
SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE
|
WO2009069736A1
(ja)
|
2007-11-28 |
2009-06-04 |
Kyowa Hakko Kirin Co., Ltd. |
含窒素化合物
|
US7973051B2
(en)
|
2007-11-30 |
2011-07-05 |
Hoffman-La Roche Inc. |
Aminothiazoles as FBPase inhibitors for diabetes
|
CN101450963B
(zh)
|
2007-11-30 |
2012-03-14 |
中国科学院上海药物研究所 |
葫芦烷型三萜皂苷化合物、其药物组合物及其制备方法和用途
|
CA2706576A1
(en)
|
2007-11-30 |
2009-06-04 |
F. Hoffmann-La Roche Ag |
Pyridine compounds
|
EP2247602B1
(en)
|
2007-11-30 |
2013-04-03 |
Novartis AG |
Adamantyl o-glucuronide derivatives as inhibitors of dipeptidyl peptidase iv for the treatment of diabetes
|
WO2009071895A1
(en)
|
2007-12-04 |
2009-06-11 |
Ucb Pharma S.A. |
Fused thiazole and thiophene derivatives as kinase inhibitors
|
CA2706632A1
(en)
|
2007-12-04 |
2009-06-11 |
Merck Frosst Canada Ltd. |
Substituted 2-naphthoic acids as antagonists of gpr105 activity
|
GB0723747D0
(en)
|
2007-12-04 |
2008-12-31 |
Ucb Pharma Sa |
Therapeutic agents
|
WO2009071890A1
(en)
|
2007-12-04 |
2009-06-11 |
Ucb Pharma S.A. |
Tricyclic kinase inhibitors
|
WO2009072581A1
(ja)
|
2007-12-05 |
2009-06-11 |
Aska Pharmaceutical Co., Ltd. |
ラクタム化合物又はその塩及びppar活性化剤
|
EP2229368A1
(en)
|
2007-12-11 |
2010-09-22 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
US8883963B2
(en)
|
2007-12-11 |
2014-11-11 |
Cadila Healthcare Limited |
Peptidomimetics with glucagon antagonistic and GLP 1 agonistic activities
|
GB0724251D0
(en)
|
2007-12-12 |
2008-02-06 |
Univ Edinburgh |
Therapeutic compounds and their use
|
JP5650540B2
(ja)
|
2007-12-12 |
2015-01-07 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
代謝障害のためのカルボキサミド、スルホンアミド、およびアミン化合物
|
UA101004C2
(en)
|
2007-12-13 |
2013-02-25 |
Теракос, Инк. |
Derivatives of benzylphenylcyclohexane and use thereof
|
DE102007061757A1
(de)
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
Substituierte 2-Phenylpyrimidin-5-carbonsäuren und ihre Verwendung
|
WO2009080032A1
(en)
|
2007-12-20 |
2009-07-02 |
Fertin Pharma A/S |
Compressed chewing gum comprising a systemically active small peptide
|
JP5364103B2
(ja)
|
2007-12-20 |
2013-12-11 |
エルジー・ライフ・サイエンシーズ・リミテッド |
グルコキナーゼ活性化剤およびそれを活性成分として含有する医薬組成物
|
WO2009080024A1
(en)
|
2007-12-20 |
2009-07-02 |
Fertin Pharma A/S |
Compressed chewing gum comprising an incretin mimetic
|
DE102007061756A1
(de)
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
Substituierte 4-Aminopyrimidin-5-carbonsäuren und ihre Verwendung
|
IE20070928A1
(en)
|
2007-12-21 |
2009-09-30 |
Giuliani Int Ltd |
Multi target ligands
|
CA2710109C
(en)
|
2007-12-21 |
2016-07-19 |
Lg Life Sciences Ltd. |
Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent
|
WO2009081782A1
(ja)
|
2007-12-25 |
2009-07-02 |
Banyu Pharmaceutical Co., Ltd. |
N-ピラゾール-2-ピリジンカルボキサミド誘導体
|
ATE549332T1
(de)
|
2007-12-26 |
2012-03-15 |
Sanofi Sa |
Zyklische pyridyl-n-(1,3,4)-thiadiazol-2-yl- benzol-sulfonamide, verfahren für ihre herstellung und anwendung als pharmaka
|
CN101468988A
(zh)
|
2007-12-26 |
2009-07-01 |
上海恒瑞医药有限公司 |
哌嗪类衍生物,其制备方法及其在医药上的应用
|
JP5144683B2
(ja)
|
2007-12-27 |
2013-02-13 |
キッセイ薬品工業株式会社 |
ピラゾール誘導体のモノセバシン酸塩
|
TW200938200A
(en)
|
2007-12-28 |
2009-09-16 |
Dainippon Sumitomo Pharma Co |
Methyl-substituted piperidine derivative
|
WO2009083553A1
(en)
|
2007-12-31 |
2009-07-09 |
Rheoscience A/S |
Azine compounds as glucokinase activators
|
GB0800035D0
(en)
|
2008-01-02 |
2008-02-13 |
Glaxo Group Ltd |
Compounds
|
TW200934490A
(en)
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
MX2010007593A
(es)
|
2008-01-10 |
2010-10-13 |
Sun Pharma Advanced Res Co Ltd |
Derivados novedosos de acil cianopirrolidinas.
|
GB0800383D0
(en)
|
2008-01-10 |
2008-02-20 |
Univ Strathclyde |
Weight reducing compounds
|
CL2009000004A1
(es)
|
2008-01-15 |
2010-02-19 |
Lilly Co Eli |
Forma cristalina de r-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida; composicion farmaceutica que comprende a dicha forma cristalina; y uso para el tratamiento de diabetes o hiperglicemia.
|
CL2008003653A1
(es)
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
US20100022590A1
(en)
|
2008-01-17 |
2010-01-28 |
Biovitrum Ab (Publ.) |
Novel compounds
|
CN101918363B
(zh)
|
2008-01-18 |
2012-09-05 |
安斯泰来制药株式会社 |
苯乙酰胺衍生物
|
BRPI0821827A2
(pt)
|
2008-01-24 |
2015-06-16 |
Merck Patent Ges Mit Beschränkter Haftung |
Derivados de beta-aminoácidos para tratamento de diabetes
|
AU2009207297B2
(en)
|
2008-01-24 |
2011-11-10 |
Panacea Biotec Limited |
Novel heterocyclic compounds
|
JP5490020B2
(ja)
|
2008-01-24 |
2014-05-14 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状カルバゼート及びセミカルバジドインヒビター
|
US20090238879A1
(en)
|
2008-01-24 |
2009-09-24 |
Northwestern University |
Delivery scaffolds and related methods of use
|
TW200936136A
(en)
|
2008-01-28 |
2009-09-01 |
Sanofi Aventis |
Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application
|
EP2090578A1
(en)
|
2008-01-29 |
2009-08-19 |
Sanofi-Aventis |
Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta
|
EP2090579A1
(en)
|
2008-01-29 |
2009-08-19 |
Sanofi-Aventis |
Substituted heteroarylamide diazepinopyrimidone derivatives
|
EP2085399A1
(en)
|
2008-01-29 |
2009-08-05 |
Sanofi-Aventis |
substituted arylamide oxazepinopyrimidone derivatives
|
EP2085400A1
(en)
|
2008-01-29 |
2009-08-05 |
Sanofi-Aventis |
Substituted heteroarylamide oxazepinopyrimidone derivatives
|
WO2009096503A1
(ja)
|
2008-01-31 |
2009-08-06 |
Daiichi Sankyo Company, Limited |
ベンジルフェニルグルコピラノシド誘導体
|
MX2010008376A
(es)
|
2008-02-04 |
2011-02-22 |
Mercury Therapeutics Inc |
Moduladores ampk.
|
JP2011510966A
(ja)
|
2008-02-04 |
2011-04-07 |
アストラゼネカ アクチボラグ |
4−[4−(2−アダマンチルカルバモイル)−5−tert−ブチル−ピラゾル−1−イル]安息香酸の新規な結晶形態
|
ES2425190T3
(es)
|
2008-02-06 |
2013-10-14 |
Daiichi Sankyo Company, Limited |
Nuevo derivado de fenilpirrol
|
WO2009099171A1
(ja)
|
2008-02-07 |
2009-08-13 |
Takeda Pharmaceutical Company Limited |
医薬
|
WO2009099172A1
(ja)
|
2008-02-07 |
2009-08-13 |
Takeda Pharmaceutical Company Limited |
医薬
|
EP2252598A2
(en)
|
2008-02-11 |
2010-11-24 |
Vitae Pharmaceuticals, Inc. |
1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
ATE531696T1
(de)
|
2008-02-12 |
2011-11-15 |
Boehringer Ingelheim Int |
Harnstoff-derivate von benzomorphanen, entsprechende gerüste, medikamente mit solchen verbindungen und ihre verwendung
|
US8263630B2
(en)
|
2008-02-12 |
2012-09-11 |
Bristol-Myers Squibb Company |
1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
PL384446A1
(pl)
|
2008-02-12 |
2009-08-17 |
Adamed Spółka Z Ograniczoną Odpowiedzialnością |
Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania
|
UY31651A1
(es)
|
2008-02-13 |
2009-09-30 |
|
Nuevos derivados de fluoroglicósidos aromáticos, medicamentos que comprenden estos compuestos y uso de los mismos.
|
WO2009102460A2
(en)
|
2008-02-15 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
JP2011513232A
(ja)
|
2008-02-22 |
2011-04-28 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Gpr119活性のモジュレーターとしての化合物および組成物
|
JP2011513233A
(ja)
|
2008-02-22 |
2011-04-28 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Gpr119活性モジュレーターとしての化合物および組成物
|
JP2011513234A
(ja)
|
2008-02-22 |
2011-04-28 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Gpr119活性モジュレーターとしての化合物および組成物
|
KR100864584B1
(ko)
|
2008-02-25 |
2008-10-24 |
성균관대학교산학협력단 |
비오틴으로 수식된 엑센딘 유도체, 이의 제조방법 및 이의용도
|
WO2009106203A1
(en)
|
2008-02-25 |
2009-09-03 |
Merck Patent Gmbh |
Glucokinase activators
|
GB0803494D0
(en)
|
2008-02-26 |
2008-04-02 |
Sterix Ltd |
Compound
|
US8383629B2
(en)
|
2008-02-27 |
2013-02-26 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
|
CA2716385A1
(en)
|
2008-02-27 |
2009-09-03 |
Lars Thore Burgdorf |
Carboxamide-heteroaryl derivatives for the treatment of diabetes
|
WO2009106561A1
(en)
|
2008-02-27 |
2009-09-03 |
Biovitrum Ab (Publ) |
Pyrazine compounds for treating gpr119 related disorders
|
WO2009106565A1
(en)
|
2008-02-27 |
2009-09-03 |
Biovitrum Ab (Publ) |
Agonists of gpr119
|
FR2928149B1
(fr)
|
2008-02-29 |
2011-01-14 |
Sanofi Aventis |
Composes derives d'azetidines, leur preparation et leur application en therapeutique
|
PT2247587E
(pt)
|
2008-03-01 |
2014-07-10 |
Merck Patent Gmbh |
Identificação, optimização e utilização de epitopos crípticos hla-b7 para imunoterapia
|
WO2009109998A1
(en)
|
2008-03-03 |
2009-09-11 |
Lupin Limited |
Novel protein tyrosine phosphatase - ib inhibitors
|
WO2009109999A1
(en)
|
2008-03-03 |
2009-09-11 |
Lupin Limited |
Novel protein tyrosine phosphatase - ib inhibitors
|
KR101589628B1
(ko)
|
2008-03-05 |
2016-01-28 |
메르크 파텐트 게엠베하 |
인슐린 분비 자극제들로서의 피리도피라지논 유도체들, 이들을 얻기 위한 방법들 및 당뇨병 치료를 위한 이들의 용도
|
US8436043B2
(en)
|
2008-03-05 |
2013-05-07 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
KR101637381B1
(ko)
|
2008-03-05 |
2016-07-07 |
메르크 파텐트 게엠베하 |
인슐린 분비 자극제들로서의 피라지논 유도체들, 이들을 얻기 위한 방법들 및 당뇨병 치료를 위한 이들의 용도
|
WO2009111239A2
(en)
|
2008-03-05 |
2009-09-11 |
National Health Research Institutes |
Pyrrolidine derivatives
|
EP2260017A1
(en)
|
2008-03-06 |
2010-12-15 |
Amgen, Inc |
Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
|
AU2009221722B2
(en)
|
2008-03-07 |
2014-12-18 |
Vtv Therapeutics Llc |
Oxadiazoanthracene compounds for the treatment of diabetes
|
KR20100137452A
(ko)
|
2008-03-10 |
2010-12-30 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
비시클릭 피롤 화합물
|
EP2262498A2
(en)
|
2008-03-10 |
2010-12-22 |
Vertex Pharmceuticals Incorporated |
Pyrimidines and pyridines useful as inhibitors of protein kinases
|
GB0804685D0
(en)
|
2008-03-13 |
2008-04-16 |
Univ Edinburgh |
Therapeutic compounds and their use
|
CA2718038A1
(en)
|
2008-03-14 |
2009-09-17 |
Exelixis, Inc. |
Azabicyclo [3.2.1] octyl derivatives as 11 beta-hsd1 modulators
|
WO2009117421A2
(en)
|
2008-03-17 |
2009-09-24 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
EP2274287B1
(en)
|
2008-03-18 |
2016-03-09 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
FR2928836B1
(fr)
|
2008-03-21 |
2011-08-26 |
Servier Lab |
Forme galenique secable permettant une liberation modifiee du principe actif
|
PE20091674A1
(es)
|
2008-03-27 |
2009-11-04 |
Lilly Co Eli |
Antagonistas del receptor de glucagon
|
US20090247532A1
(en)
|
2008-03-28 |
2009-10-01 |
Mae De Ltd. |
Crystalline polymorph of sitagliptin phosphate and its preparation
|
JP5711655B2
(ja)
|
2008-03-31 |
2015-05-07 |
シマベイ セラピューティクス, インコーポレーテッド |
オキシメチレンアリール化合物およびその使用
|
US9242011B2
(en)
|
2008-04-01 |
2016-01-26 |
Novo Nordisk A/S |
Insulin albumin conjugates
|
FR2929615B1
(fr)
|
2008-04-02 |
2010-12-17 |
Tfchem |
Composes c-aryl glycosides pour le traitement du diabete et de l'obesite.
|
AR071175A1
(es)
|
2008-04-03 |
2010-06-02 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
|
WO2009125434A2
(en)
|
2008-04-07 |
2009-10-15 |
Cadila Healthcare Limited |
Oxime derivatives
|
DE102008017590A1
(de)
|
2008-04-07 |
2009-10-08 |
Merck Patent Gmbh |
Glucopyranosidderivate
|
US20110263557A1
(en)
|
2008-04-07 |
2011-10-27 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
EP2276760B1
(en)
|
2008-04-10 |
2014-04-09 |
Takeda Pharmaceutical Company Limited |
Fused ring compounds and use thereof
|
PL2262500T3
(pl)
|
2008-04-11 |
2016-09-30 |
|
Pochodne tienopirydonowe jako aktywatory kinazy białkowej aktywowanej przez amp (ampk)
|
EP2297129B1
(en)
|
2008-04-14 |
2013-07-24 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
|
CN104672220B
(zh)
|
2008-04-15 |
2017-09-22 |
日本化学医药株式会社 |
过氧化物酶体增殖剂活化受体的活化剂
|
US8258134B2
(en)
|
2008-04-16 |
2012-09-04 |
Hoffmann-La Roche Inc. |
Pyridazinone glucokinase activators
|
US7741327B2
(en)
|
2008-04-16 |
2010-06-22 |
Hoffmann-La Roche Inc. |
Pyrrolidinone glucokinase activators
|
WO2009128421A1
(ja)
|
2008-04-16 |
2009-10-22 |
キッセイ薬品工業株式会社 |
ピラゾール誘導体の1/2フマル酸塩
|
EP2266983B1
(en)
|
2008-04-16 |
2013-06-05 |
Takeda Pharmaceutical Company Limited |
Nitrogenated 5-membered heterocyclic compound
|
DE102008019838A1
(de)
|
2008-04-19 |
2009-12-10 |
Boehringer Ingelheim International Gmbh |
Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
|
TW200944526A
(en)
|
2008-04-22 |
2009-11-01 |
Vitae Pharmaceuticals Inc |
Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
MX2010011591A
(es)
|
2008-04-22 |
2010-11-09 |
Astrazeneca Ab |
Pirimidin-5-carboxamidas sustituidas 281.
|
CN101565408A
(zh)
|
2008-04-25 |
2009-10-28 |
国家新药筛选中心 |
一类受体信号转导增效剂,其制备方法和用途
|
WO2009133099A2
(en)
|
2008-04-28 |
2009-11-05 |
Novo Nordisk A/S |
Insulin precursors for diabetes treatment
|
RS54146B1
(en)
|
2008-04-28 |
2015-12-31 |
Kyorin Pharmaceutical Co. Ltd. |
CIKLOPENTILAKRILAMIDA DERIVATIVES
|
US8124636B2
(en)
|
2008-04-30 |
2012-02-28 |
Hoffmann-La Roche Inc. |
Imidazolidinone derivatives as 11B-HSD1 inhibitors
|
WO2009134400A1
(en)
|
2008-05-01 |
2009-11-05 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
CL2009001058A1
(es)
|
2008-05-01 |
2010-09-10 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
|
JP5451752B2
(ja)
|
2008-05-01 |
2014-03-26 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
|
EP2291370B1
(en)
|
2008-05-01 |
2013-11-27 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
WO2009135581A2
(en)
|
2008-05-05 |
2009-11-12 |
Merck Patent Gmbh |
Novel nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
|
DK2280952T3
(da)
|
2008-05-05 |
2012-07-23 |
Merck Patent Gmbh |
Thienopyridinonderivater som amp-aktiverede proteinkinase(ampk)aktivatorer
|
ITMI20080846A1
(it)
|
2008-05-09 |
2009-11-10 |
Andrea Balsari |
Composti a struttura glicosidica attivi nella terapia di stati infiammatori locali e sistemici
|
WO2009139340A1
(ja)
|
2008-05-12 |
2009-11-19 |
武田薬品工業株式会社 |
ピラゾール化合物
|
EP2288596B1
(en)
|
2008-05-13 |
2016-11-30 |
Boehringer Ingelheim International GmbH |
Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
|
JP4643760B2
(ja)
|
2008-05-14 |
2011-03-02 |
株式会社三和化学研究所 |
Dpp−iv阻害薬と他の糖尿病治療薬との併用又は組み合せからなる医薬
|
AU2009246167B2
(en)
|
2008-05-16 |
2013-08-22 |
Takeda California, Inc. |
Glucokinase activators
|
EP2291358B1
(en)
|
2008-05-16 |
2018-03-28 |
Merck Sharp & Dohme Corp. |
Glucagon receptor antagonists, compositions, and methods for their use
|
US8188098B2
(en)
|
2008-05-19 |
2012-05-29 |
Hoffmann-La Roche Inc. |
GPR119 receptor agonists
|
EP2297117B1
(en)
|
2008-05-19 |
2012-10-31 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
US20090291982A1
(en)
|
2008-05-22 |
2009-11-26 |
Astrazeneca Ab |
New Substituted Oxindole Derivative 352
|
ES2423793T3
(es)
|
2008-05-26 |
2013-09-24 |
Genfit |
Compuestos agonistas de PPAR, preparación y usos para el tratamiento de la diabetes y/o dislipidemias
|
US8263547B2
(en)
|
2008-05-28 |
2012-09-11 |
Massachusetts Institute Of Technology |
DISC-1 pathway activators in the control of neurogenesis
|
CA2725316A1
(en)
|
2008-06-02 |
2009-12-10 |
Banyu Pharmaceutical Co., Ltd. |
Novel isoxazole derivative
|
WO2009147121A1
(en)
|
2008-06-02 |
2009-12-10 |
Smithkline Beecham Corporation |
Carboxyl substituted indoles for use as ppar alpha modulators
|
US20110086074A1
(en)
|
2008-06-02 |
2011-04-14 |
Dr. Reddy's Laboratories Ltd. |
Combinations of niacin and an oxicam
|
WO2009149148A2
(en)
|
2008-06-03 |
2009-12-10 |
Trustees Of Tufts College |
Long-acting glp-1 derivatives, and methods of treating cardiac dysfunction
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
PT2300472E
(pt)
|
2008-06-06 |
2012-02-20 |
Boehringer Ingelheim Int |
Miméticos de glucocorticóides, métodos de os preparar, composições farmacêuticas e suas utilizações
|
CA2727373A1
(en)
|
2008-06-09 |
2009-12-17 |
Sanofi-Aventis |
Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
|
WO2010000353A1
(en)
|
2008-06-09 |
2010-01-07 |
Sanofi-Aventis |
Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
|
EP2288605B1
(en)
|
2008-06-09 |
2014-06-25 |
Sanofi |
Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
|
WO2009150144A1
(en)
|
2008-06-10 |
2009-12-17 |
Inovacia Ab |
New gpr119modulators
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
MY155695A
(en)
|
2008-06-16 |
2015-11-13 |
Merck Patent Gmbh |
Quinoxalinedione derivatives
|
AU2009261441B2
(en)
|
2008-06-17 |
2013-01-10 |
Glytech, Inc. |
Oligosaccharide chain added glp-1 peptide
|
EP2676673B1
(en)
|
2008-06-17 |
2016-11-16 |
Indiana University Research and Technology Corporation |
Glucagon/glp-1 receptor co-agonists
|
RU2560254C2
(ru)
|
2008-06-17 |
2015-08-20 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
АНАЛОГИ ГЛЮКАГОНА, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ РАСТВОРИМОСТЬЮ И СТАБИЛЬНОСТЬЮ В БУФЕРАХ С ФИЗИОЛОГИЧЕСКИМИ ЗНАЧЕНИЯМИ Ph
|
WO2010008739A2
(en)
|
2008-06-20 |
2010-01-21 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|
BRPI0914629A2
(pt)
|
2008-06-24 |
2019-09-24 |
Irm Llc |
compostos e métodos para a modulação de receptores acoplados à proteína g
|
EP2138492A1
(en)
|
2008-06-26 |
2009-12-30 |
Sanofi-Aventis |
Substituted pyrimidin-4-one derivatives
|
EP2138485A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
Substituted N-Oxide pyrazine derivatives
|
EP2138495A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
Substituted pyrimido[2,1-a]isoquinolin-4-one derivatives
|
EP2138488A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases
|
EP2138493A1
(en)
|
2008-06-26 |
2009-12-30 |
Sanofi-Aventis |
Substituted pyrimidone derivatives
|
EP2138498A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
Substituted tricyclic derivatives against neurodegenerative diseases
|
EP2138494A1
(en)
|
2008-06-26 |
2009-12-30 |
Sanofi-Aventis |
Substituted alkyl pyrimidin-4-one derivatives
|
GB0812031D0
(en)
|
2008-07-01 |
2008-08-06 |
7Tm Pharma As |
Thiazole derivatives
|
EP2650296A1
(en)
|
2008-07-03 |
2013-10-16 |
Ratiopharm GmbH |
Crystalline salts of sitagliptin
|
WO2010006214A1
(en)
|
2008-07-09 |
2010-01-14 |
Ambrx, Inc. |
Fgf-21 neutralizing antibodies and their uses
|
GB0812649D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
GB0812642D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
GB0812648D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
KR20110036609A
(ko)
|
2008-07-10 |
2011-04-07 |
프로시디온 리미티드 |
피페리디닐 gpcr 작용제
|
ATE557024T1
(de)
|
2008-07-10 |
2012-05-15 |
Prosidion Ltd |
Piperidinverbindungen als gpcr-agonisten
|
GB0812641D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
CN102137844B
(zh)
|
2008-07-11 |
2013-05-22 |
Irm责任有限公司 |
作为gpr119活性调控剂的化合物和组合物
|
EP2147910A1
(en)
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
US8501940B2
(en)
|
2008-07-15 |
2013-08-06 |
Hoffmann-La Roche Inc. |
Tetrahydrocinnoline derivatives
|
TW201006821A
(en)
|
2008-07-16 |
2010-02-16 |
Bristol Myers Squibb Co |
Pyridone and pyridazone analogues as GPR119 modulators
|
CA2730606A1
(en)
|
2008-07-16 |
2010-01-21 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
EP2328897A1
(en)
|
2008-07-16 |
2011-06-08 |
Schering Corporation |
Bicyclic heterocycle derivatives and their use as gpcr modulators
|
AU2009270971A1
(en)
|
2008-07-16 |
2010-01-21 |
Schering Corporation |
Bicyclic Heterocycle Derivatives and use thereof as GPR119 modulators
|
TWI472521B
(zh)
|
2008-07-17 |
2015-02-11 |
Lexicon Pharmaceuticals Inc |
(2s,3r,4r,5s,6r)-2-(4-氯-3-(4-乙氧苄基)苯基)-6-(甲硫)四氫-2h-哌喃-3,4,5-三醇的固體形態與其使用方法
|
CA2729998A1
(en)
|
2008-07-25 |
2010-01-28 |
Boehringer Ingelheim International Gmbh |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
WO2010011917A1
(en)
|
2008-07-25 |
2010-01-28 |
Glaxosmithkline Llc |
SEH AND 11β-HSD1 DUAL INHIBITORS
|
CA2730208C
(en)
|
2008-07-25 |
2016-10-25 |
Boehringer Ingelheim International Gmbh |
1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
|
EP2313360B1
(en)
|
2008-07-28 |
2012-09-05 |
Syddansk Universitet |
Compounds for the treatment of metabolic diseases
|
CA2732266A1
(en)
|
2008-07-28 |
2010-02-04 |
Emory University |
Treating various disorders using trkb agonists
|
EP2318370A1
(en)
|
2008-07-29 |
2011-05-11 |
Pfizer Inc. |
Fluorinated heteroaryls
|
JP2011529903A
(ja)
|
2008-07-30 |
2011-12-15 |
オンコセラピー・サイエンス株式会社 |
ベンゾイミダゾール誘導体およびこれを含むグリコーゲンシンターゼキナーゼ3β阻害剤
|
WO2010014593A1
(en)
|
2008-07-30 |
2010-02-04 |
Smithkline Beecham Corporation |
Chemical compounds and uses
|
US20100105746A1
(en)
|
2008-08-01 |
2010-04-29 |
Clary Clish |
Method for treating metabolic diseases
|
ATE529402T1
(de)
|
2008-08-01 |
2011-11-15 |
Centre Nat Rech Scient |
3',6-substituierte indirubine und ihre biologischen anwendungen
|
MX2011001333A
(es)
|
2008-08-04 |
2011-03-15 |
Astrazeneca Ab |
Derivados de pirazolo [3, 4] pirimidin-4-ilo y sus usos para tratar la diabetes y obesidad.
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
JP2011530507A
(ja)
|
2008-08-07 |
2011-12-22 |
イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ |
グルコース依存性インスリン分泌刺激ポリペプチドアナログ
|
BRPI0917001A2
(pt)
|
2008-08-07 |
2016-02-16 |
Ipsen Pharma Sas |
composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
|
CN104231070B
(zh)
|
2008-08-07 |
2017-09-01 |
益普生制药股份有限公司 |
N‑端修饰的葡萄糖依赖性促胰岛素多肽(gip)类似物
|
AU2009280017B2
(en)
|
2008-08-07 |
2013-01-10 |
Ipsen Pharma S.A.S. |
Analogues of glucose-dependent insulinotropic polypeptide
|
WO2010016936A1
(en)
|
2008-08-07 |
2010-02-11 |
Ipsen Pharma S.A.S. |
Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide
|
WO2010018438A2
(en)
|
2008-08-11 |
2010-02-18 |
Hetero Research Foundation |
Tetrazole glycosides
|
WO2010018435A1
(en)
|
2008-08-11 |
2010-02-18 |
Hetero Research Foundation |
Amide glycosides
|
WO2010019828A1
(en)
|
2008-08-13 |
2010-02-18 |
Metabasis Therapeutics, Inc. |
Glucagon receptor antagonists
|
JP2012500181A
(ja)
|
2008-08-15 |
2012-01-05 |
Msd株式会社 |
アセチルピロリジニルインドール誘導体
|